Thrombus aspiration system and methods for controlling blood loss

Information

  • Patent Grant
  • 11931502
  • Patent Number
    11,931,502
  • Date Filed
    Thursday, April 27, 2023
    a year ago
  • Date Issued
    Tuesday, March 19, 2024
    a month ago
Abstract
Aspiration systems and methods for controlling blood loss during thrombus removal are disclosed herein. The systems include an aspiration catheter, an aspiration tubing, a receptacle for collecting aspirated blood, a vacuum line coupled to the receptacle, and a sensor configured to measure a flow parameter associated with a liquid within an aspiration lumen. The systems further include a regulator configured to adjust a vacuum pressure within the vacuum line, and a vacuum controller operably coupled to the sensor and the regulator. The vacuum controller is configured to receive the flow parameter from the sensor, compare the flow parameter to a target range for the flow parameter, and send an automatic control signal to the regulator based on a comparison of the flow parameter to the target range. The automatic control signal causes the regulator to adjust the vacuum pressure within the vacuum line.
Description
FIELD

This invention relates to medical devices for thrombus removal, and more particularly to thrombus aspiration systems.


BACKGROUND

It is often desirable to remove tissue from the body in a minimally invasive manner as possible, so as not to damage other tissues. For example, removal of tissue (e.g., blood clots) from the vasculature may improve patient conditions and quality of life.


Many vascular system problems stem from insufficient blood flow through blood vessels. One causes of insufficient or irregular blood flow is a blockage within a blood vessel referred to as a blood clot, or thrombus. Thrombi can occur for many reasons, including after a trauma such as surgery, or due to other causes. For example, a large percentage of the more than 1.2 million heart attacks in the United States are caused by blood clots (thrombi) which form within a coronary artery.


When a thrombus forms, it may effectively stop the flow of blood through the zone of formation. If the thrombus extends across the interior diameter of an artery, it may cut off the flow of blood through the artery. If one of the coronary arteries is 100% thrombosed, the flow of blood is stopped in that artery, resulting in a shortage of oxygen carrying red blood cells, e.g., to supply the muscle (myocardium) of the heart wall. Such a thrombosis is unnecessary to prevent loss of blood but can be undesirably triggered within an artery by damage to the arterial wall from atherosclerotic disease. Thus, the underlying disease of atherosclerosis may not cause acute oxygen deficiency (ischemia) but can trigger acute ischemia via induced thrombosis. Similarly, thrombosis of one of the carotid arteries can lead to stroke because of insufficient oxygen supply to vital nerve centers in the cranium. Oxygen deficiency reduces or prohibits muscular activity, can cause chest pain (angina pectoris), and can lead to death of myocardium which permanently disables the heart to some extent. If the myocardial cell death is extensive, the heart will be unable to pump sufficient blood to supply the body's life sustaining needs. The extent of ischemia is affected by many factors, including the existence of collateral blood vessels and flow which can provide the necessary oxygen.


Clinical data indicates that clot removal may be beneficial or even necessary to improve outcomes. For example, in the peripheral vasculature, inventions and procedures can reduce the need for an amputation by 80 percent. The ultimate goal of any modality to treat these conditions of the arterial or venous system is to remove the blockage or restore patency, quickly, safely, and cost effectively. This may be achieved by thrombus dissolution, fragmentation, thrombus aspiration or a combination of these methods.


Catheter directed thrombectomy and thrombolysis are commonly perceived to be less traumatic, less likely to decrease the morbidity and mortality associated with conventional surgical techniques. In recent years, direct administration of chemical lysing agents into the coronary arteries has shown to be of some benefit to patients who have thrombosed coronary arteries. In this procedure, a catheter is placed immediately in front of the blockage and a drip of streptokinase is positioned to be directed at the upstream side of the thrombus. Streptokinase is an enzyme which is able in time to dissolve the fibrin molecule. This procedure can take several hours and is not always successful in breaking up the thrombus. Furthermore, it can lead to downstream thrombus fragments (emboli) which can lead to blockage of small diameter branches.


Thrombectomy is a technique for mechanical removal of blood clots in an artery or vein. It refers to physically removing a clot as opposed to employing chemical lysis to dissolve it. Multiple devices have been introduced to break up and remove clot and plaque, but each has its own shortcomings. Specifically, the existing systems do not provide adequate methods for breaking up the clot into smaller pieces for subsequent aspiration. Also, they do not provide a method for removing the thrombectomy device over a guidewire and reinserting into the same location to complete the procedure. Furthermore, conventional aspiration systems offer little control over the amount of blood lost during the procedure. There is a need for improved thrombectomy devices and aspiration systems that are safer and more effective for removing thrombus and plaque from the vascular system.


SUMMARY

Aspiration systems and methods are disclosed herein for controlling blood loss during thrombus removal. The aspiration systems include, at least, an aspiration catheter, a thrombus retrieval device extending through the aspiration catheter, and an aspiration tubing fluidically coupled to the aspiration catheter. An aspiration lumen extends through the aspiration catheter and the aspiration tubing. A sensor measures a flow parameter associated with a liquid within the aspiration lumen. The aspiration systems further include a receptacle configured to collect liquid aspirated by the aspiration catheter. A vacuum line is fluidically coupled to the receptacle, and a regulator adjusts the vacuum pressure within the vacuum line. A vacuum controller is operably coupled to the sensor and the regulator. The vacuum controller is configured to receive the flow parameter from the sensor, compare the flow parameter to a target range for the flow parameter, and send an automatic control signal to the regulator based on a comparison of the flow parameter to the target range. The automatic control signal causes the regulator to adjust the vacuum pressure within the vacuum line.


In some implementations, the automatic control signal causes the regulator to decrease the vacuum pressure upon a determination that the flow parameter is above an upper limit of the target range, and to increase the vacuum pressure upon a determination that the flow parameter is below a lower limit of the target range. For example, the upper limit can be a flow rate from 70 mL per minute to 130 mL per minute, and the lower limit can be a flow rate from 0 mL per minute to 40 mL per minute. In some examples, the vacuum controller is configured to adjust the flow rate to an intermediate level, such as, for example, from 20 mL per minute to 50 mL per minute. Increases and decreases in vacuum pressure can occur in a stepwise manner. In some implementations, the vacuum controller can activate an aspiration program that causes increases and decreases of vacuum pressure in a stepwise manner. In some examples, the aspiration program is activated upon receipt of information from one or more manual inputs in communication with the regulator, the vacuum controller, or both.


The receptacle is fluidically coupled to the aspiration tubing, the aspiration catheter, and the vacuum line. In some implementations, an intake port on the receptacle provides the coupling between the receptacle and the aspiration tubing, and a vacuum port on the receptacle provides the coupling between the receptacle and the vacuum line. The receptacle can include a receptacle vent in communication with the regulator or the vacuum controller. The receptacle vent opens upon receipt of a venting signal from the regulator or vacuum controller.


The aspiration system includes one or more sensors for measuring flow parameters, such as, for example, a flow rate. Some implementations can include a plurality of sensors configured to measure one or more parameters associated with fluid flow at disparate points along a length of the aspiration lumen, and to send the measured parameters to the vacuum controller. The sensor may or may not contact the liquid within the aspiration lumen.


Some implementations can further include an air leak sensor in communication with the vacuum controller or the regulator. The air leak sensor can detect air flow through the aspiration tubing and send a leak signal to the vacuum controller, the regulator, or the vacuum pump upon detection of air through the aspiration tubing. The vacuum controller, regulator, or pump can slow or stop the vacuum flow while the air leak is addressed. In some implementations, the vacuum controller is configured to delay detection of air leaks during a vacuum initialization period. Alternatively, or in addition, the vacuum controller can be configured to delay controlling the vacuum in response to detection of air leaks during a vacuum initialization period.


In some implementations of the system, the regulator adjusts the vacuum pressure within the vacuum line by manipulating a valve that opens the vacuum line to the atmosphere. In some implementations, the regulator adjusts the vacuum pressure within the vacuum line by manipulating a valve that alters the flow capacity of the vacuum line. The vacuum line can have a disposable portion and a reusable portion. The disposable portion can be coupled to the reusable portion at a connector. Some implementations of the system include a vacuum pump. Some implementations can include a power sensor configured to synchronize the delivery of power between the pump and the vacuum controller.


The vacuum controller sends signals to one or more components of the system to regulate flow of air in the vacuum line and blood through the aspiration lumen. The vacuum controller can be, in some examples, a microprocessor controller. It can include an analog to digital converter and a digital to analog converter. In some examples, the vacuum controller is configured to measure a frequency from the flow parameter. The vacuum controller can operate independently. For example, the vacuum controller is capable of operating without input from external sources such as a computer.


Some implementations of the systems include one or more manual inputs in communication with the vacuum controller, the regulator, and/or a receptacle vent. The manual input is configured to accept a manual command and send a first manual control signal responsive to the manual command to one or more of the vacuum controller, the regulator, and/or the receptacle vent. In some examples, upon receipt of the first manual control signal, the vacuum controller stops one or more steps of comparing the flow parameter to a target range for the flow parameter, forming an automatic control signal, and/or sending the automatic control signal to the regulator. In some implementations, the vacuum controller is configured to send a second manual control signal to the regulator and/or receptacle vent based on the first manual control signal. The regulator controls the vacuum pressure within the vacuum line upon receipt of the first manual control signal and/or the second manual control signal. The receptacle vent opens or shuts upon receipt of the first manual control signal and/or the second manual control signal. Some systems can also include an indicator in communication with the flow sensor. The indicator is configured to inform a user of a characteristic of the flow parameter.


In some implementations, at least one braided assembly extends over a distal region of the thrombus retrieval device. The braided assembly can include a braid having a shape memory of a collapsed configuration.


In some implementations, the aspiration system further comprises a clamp coupled to the aspiration tubing and a switch operably coupled to the clamp, the switch comprising a closed configuration and an open configuration, wherein the switch in the closed configuration causes the clamp to stop fluid flow through the aspiration tubing, and wherein the switch in the open configuration causes the clamp to allow fluid flow through the aspiration tubing. The switch can be in communication with the vacuum controller and/or the regulator. Shifting the switch to the open configuration can send a surge protection signal to the regulator and/or to the vacuum controller. The regulator and/or the vacuum controller can reduce the vacuum pressure upon receipt of the surge protection signal.


Methods of controlling blood loss during thrombus removal are disclosed herein. The methods include positioning an aspiration catheter within the vascular system of a subject and positioning a thrombus retrieval device within the vascular system of the subject through the aspiration catheter. The aspiration catheter is fluidically connected to an aspiration tubing and a vacuum pump. Activation of the vacuum pump initiates the flow of blood through the aspiration catheter and the aspiration tubing. A sensor measures a flow parameter of the blood within the aspiration tubing. The flow parameter from the sensor is received at a vacuum controller. The flow parameter is compared to a target range for the flow parameter, and an automatic control signal is sent to the regulator based on a comparison of the flow parameter to the target range. The vacuum pressure within the vacuum line is adjusted according to information stored in the automatic control signal.


In some implementations, the vacuum pump is activated at full power, and adjustments to the vacuum pressure are regulated by the vacuum controller while the vacuum pump runs at full power.


The step of adjusting the vacuum pressure can include decreasing the vacuum pressure upon a determination that the flow parameter is above an upper limit of the target range (for example, an upper limit of a flow rate from 70 mL per minute to 130 mL per minute). The step of decreasing the vacuum pressure can include lowering the vacuum pressure in a stepwise manner. In some implementations, the vacuum pressure is decreased until the measured flow parameter reaches an intermediate level flow rate of 20 mL per minute to 50 mL per minute. Some methods include a step of activating an aspiration program upon receipt of a manual command from one or more manual inputs in communication with the regulator and/or the vacuum controller, and the aspiration program includes lowering the vacuum pressure in a stepwise manner.


The step of adjusting the vacuum pressure can include increasing the vacuum pressure upon a determination that the flow parameter is below a lower limit of the target range (for example, a lower limit of a flow rate of from 0 mL per minute to 50 mL per minute). the step of increasing the vacuum pressure can include raising the vacuum pressure in a stepwise manner. In some implementations, the vacuum pressure is raised until the measured flow parameter reaches an intermediate level flow rate of 20 mL per minute to 50 mL per minute. Some methods include a step of activating an aspiration program upon receipt of a manual command from one or more manual inputs in communication with the regulator and/or the vacuum controller, and the aspiration program includes raising the vacuum pressure in a stepwise manner.


In some implementations, the step of adjusting the vacuum pressure within the vacuum line comprises manipulating a valve that opens the vacuum line to the atmosphere. In some implementations, the step of adjusting the vacuum pressure within the vacuum line alters the flow capacity of the vacuum line.


The step of measuring a flow parameter can include measuring a flow rate. Some method implementations use a plurality of sensors to measure one or more flow parameters of the blood at disparate points along the length of the aspiration lumen. The one or more flow parameters are received at the vacuum controller. The methods can further include a step of measuring a frequency from the flow parameter at the vacuum controller.


Some method implementations can include a step of detecting air within the aspiration tubing and sending a leak signal to the regulator, the pump, or to the vacuum controller. In some implementations, the step of detecting air within the aspiration tubing or the step of sending a leak signal to the regulator or the pump is delayed during initialization of the vacuum.


Some method implementations can include a step of accepting a manual command at a manual input and sending a first manual control signal responsive to the manual command to one or more of the vacuum controller, the regulator, or a receptacle vent. Upon receipt of the first manual control signal, the vacuum controller can stops sending automatic control signals to the regulator. In some implementations, a second manual control signal is formed at the vacuum controller (based on the first manual control signal) and the second manual control signal is sent to the regulator and/or receptacle vent. Some method implementations can include a step of receiving the first manual control signal or the second manual control signal at the regulator and controlling vacuum pressure within the vacuum line based on the first manual control signal or the second manual control signal. Some method implementations can include a step of receiving the first manual control signal or the second manual control signal at the receptacle vent and opening or shutting the vent based on the first manual control signal or the second manual control signal.


Some method implementations can include a step of receiving information from the flow sensor at an indicator and informing a user of a characteristic of the flow parameter using the indicator.


Some method implementations can include a step of shifting a switch from a closed configuration to an open configuration, wherein shifting the switch to the open configuration causes a clamp coupled to the aspiration tubing to allow fluid flow through the aspiration tubing. A surge protection signal can be sent upon shifting of the switch to the open configuration and received at the controller or regulator. The vacuum pressure can be decreased upon receipt of the surge protection signal.


Some method implementations can include a step of synchronizing the delivery of power between the vacuum pump and the vacuum controller.





DESCRIPTION OF DRAWINGS

The device is explained in even greater detail in the following drawings. The drawings are merely exemplary and certain features may be used singularly or in combination with other features. The drawings are not necessarily drawn to scale.



FIG. 1A is a side section view of an implementation of the thrombectomy device having a single braided assembly in the collapsed configuration.



FIG. 1B is a side view showing the distal region of the thrombectomy device carrying the braided assembly of FIG. 1A. The braided assembly is shown in an expanded configuration.



FIG. 1C is a side view showing the distal region of the thrombectomy device of FIG. 1A. The braided assembly is not included in this view.



FIG. 1D is a cross sectional view of the implementation of FIG. 1A, taken along lines A-A of FIG. 1C.



FIG. 2 shows a side view of an implementation of a handle that can be used to control expansion and retraction of a braided assembly.



FIG. 3A is a side view of a distal region of an additional implementation of the thrombectomy device in an unexpanded configuration. The implementation has a braided assembly having multiple braided sections.



FIG. 3B is a side view of the distal region of the implementation of FIG. 3A in an expanded configuration.



FIG. 3C is a side view of the distal region of the thrombectomy device of FIG. 3A. The braided assembly is not included in this view.



FIG. 3D shows a cross sectional view taken along line 3D-3D of FIG. 3C.



FIG. 3E shows a cross sectional view taken along line 3E-3E of FIG. 3C.



FIG. 3F shows a cross sectional view taken along line 3F-3F of FIG. 3C.



FIG. 3G shows a cross sectional view taken along line 3G-3G of FIG. 3C.



FIG. 4 shows an additional implementation of the thrombectomy device having multiple expandable braided assemblies.



FIG. 5A shows a side section view of an implementation of the thrombectomy device that enables use with a guidewire.



FIG. 5B shows the implementation of FIG. 5A in an expanded configuration.



FIG. 5C is a cross section of the implementation of FIGS. 5A and 5B, taken along line B-B of FIG. 5B.



FIGS. 6A-6F show an example method of using a thrombectomy device.



FIG. 7A shows a perspective view of another implementation of a handle that can be used to control expansion and retraction of a braided assembly.



FIG. 7B shows a bottom up, inside view of the locking slider of the handle implementation of FIG. 7A.c



FIG. 7C shows a cross section of the locking slider circled in FIG. 7B.



FIG. 8 is a diagram of an aspiration system for controlling blood loss during thrombus removal.



FIG. 9 is a flow chart of a method for controlling blood loss during thrombus removal.



FIG. 10 is a line graph depicting a flow rate through an aspiration tubing over time.



FIG. 11 is another line graph depicting a flow rate through an aspiration tubing over time.



FIG. 12 is a diagram of a computing device upon which the disclosed systems may be implemented.



FIG. 13 shows a proximal end of an aspiration catheter connected via an adapter to an aspiration tubing.





DETAILED DESCRIPTION

The systems and methods disclosed herein aim to reduce the amount of blood lost during procedures that utilize aspiration to remove thrombus from the vasculature. The systems include a vacuum controller for an aspiration pump that is used in conjunction with an aspiration catheter and an aspiration tubing. The aspiration tubing is equipped with a flow sensor in communication with vacuum controller. The vacuum controller monitors the flow rate of blood being aspirated by the pump and communicates with a vacuum regulator to raise the vacuum if the flow rate gets to low (for example, when obstructed by a clot). The vacuum controller also communicates with the vacuum regulator to lower the vacuum if the flow rate gets too high. This lowering of the vacuum is a safety feature designed to prevent the system from aspirating blood instead of clot. Applying only the vacuum needed to remove the clot prevents unnecessary blood loss. Furthermore, damage to the vasculature is reduced because the amount of time the system applies full vacuum is minimized. The system can increase or decrease pressure gradually, or in a stepwise manner, to ensure the practitioner has sufficient time to respond to sudden changes in flow rate. The system can also include a variety of manual inputs to slow, pause, or stop the automated flow control processes.


The system disclosed herein integrates flow and vacuum control, using flow rate to inform the desired vacuum level. Conventional systems do not offer this feature. Many prioritize improving aspiration efficiency over controlling blood loss. Furthermore, conventional systems often adjust vacuum level based on pressure sensors within the aspiration tubing. Because the disclosed system responds specifically to the parameter of interest—the amount of blood flowing through the catheter—it responds more accurately than pressure measurement-based systems. With this system, the user can tune the flow rate, defining minimum and maximum allowed flow rates, and then automate control of the vacuum and flow rate according to those thresholds. This automation reduces the need for the practitioner to monitor and adjust the procedure for blood loss (though the practitioner is able to override the automation when necessary, via the aforementioned manual inputs). Advantageously, the system minimizes the necessary procedure time by optimizing the aspiration process.


The aspiration system can be used with a variety of catheters and vacuum pumps without changing the core aspiration system. It can be provided with all of the necessary components, or can be used with components that are provided by the clinician. Furthermore, the vacuum controller, regulator, and pump can be used in the operating theater but fluidically isolated from the patient, negating the need for extensive sterilization. Flow manipulation occurs within the vacuum line instead of the aspiration lumen—a cleaner design than some conventional systems where valves directly manipulate blood flow within the aspiration lumen. In the disclosed aspiration systems, components that do contact blood can be disposable, whereas fluidically isolated components can be reusable.


The thrombectomy devices disclosed herein remove a thrombus using a braided assembly that can be expanded to a diameter of the practitioner's choosing, enabling the practitioner to custom fit the device to the particular vessel and thrombus and during the procedure. Unlike conventional thrombectomy devices, the diameter of the disclosed braided assembly can be changed mid-procedure as needed. For example, the braided assembly can be opened to a wider diameter to apply more outward force against the thrombus should additional grip be needed for its removal. In some implementations, multiple braided assemblies can be used to address longer thrombi. Each braided assembly can be separately expanded, such that the individual assemblies have different diameters during the procedure.


The device disclosed herein is used to the remove a thrombus, clot, or plaque from the veins or arteries of the body. It includes an aspiration catheter and a retrieval device that extends through the lumen of the aspiration catheter. An expandable braided assembly extends over a distal region of the retrieval device, such that when the retrieval device exits the distal end of the aspiration catheter, the braided assembly is positioned outside of the aspiration catheter. An activation wire extends through the lumen of the retrieval device. The distal end of the activation wire exits the retrieval device at an exit point to connect to and control the expansion of a braided assembly. On the proximal end, the activation wire is attached to a tensioning element. Applying tension to the activation wire causes the braided assembly to expand to a diameter of the practitioner's choosing. For example, the practitioner may apply a first level of tension to deploy the braided assembly to a first, partially expanded configuration and then later decide to widen the diameter to the fully expanded configuration by applying a greater level of tension to the activation wire. The expanded braided assembly contacts the thrombus, clot, or plaque and is pulled proximally toward the aspiration catheter to assist in removal. Hereinafter the device and methods will be described as removing (or being configured to remove) a thrombus. However, it will be understood that the device can also be used to remove clots or plaques from the vasculature with no structural (or only slight structural) modifications. Various implementations of the thrombectomy catheter include a retrieval device with multiple braided assemblies, multiple activation wires, multiple braided sections of a single braided assembly, and retrieval devices with multiple lumens to, for example, enable use with a guidewire.


The following description of certain examples of the inventive concepts should not be used to limit the scope of the claims. Other examples, features, aspects, configurations, implementations, and advantages will become apparent to those skilled in the art from the following description. As will be realized, the device and/or methods are capable of other different and obvious aspects, all without departing from the spirit of the inventive concepts. Accordingly, the drawings and descriptions should be regarded as illustrative in nature and not restrictive.


For purposes of this description, certain advantages and novel features of the aspects and configurations of this disclosure are described herein. The described methods, systems, and apparatus should not be construed as limiting in any way. Instead, the present disclosure is directed toward all novel and nonobvious features and aspects of the various disclosed aspects, alone and in various combinations and sub-combinations with one another. The disclosed methods, systems, and apparatus are not limited to any specific aspect, feature, or combination thereof, nor do the disclosed methods, systems, and apparatus require that any one or more specific advantages be present or problems be solved.


Although the operations of exemplary aspects of the disclosed method may be described in a particular, sequential order for convenient presentation, it should be understood that disclosed aspects can encompass an order of operations other than the particular, sequential order disclosed. For example, operations described sequentially may in some cases be rearranged or performed concurrently. Further, descriptions and disclosures provided in association with one particular aspect or implementation are not limited to that aspect or implementation and may be applied to any aspect or implementation disclosed. It will understood that various changes and additional variations may be made and equivalents may be substituted for elements thereof without departing from the scope of the invention or the inventive concept thereof. Certain aspects and features of any given aspect may be translated to other aspects described herein. In addition, many modifications may be made to adapt a particular situation or device to the teachings of the invention without departing from the essential scope thereof. Therefore, it is intended that the invention not be limited to the particular implementations disclosed herein, but that the invention will include all implementations falling within the scope of the appended claims.


Features, integers, characteristics, compounds, chemical moieties, or groups described in conjunction with a particular aspect, configuration, implementation or example of the invention are to be understood to be applicable to any other aspect, configuration, implementation, or example described herein unless incompatible therewith. All of the features disclosed in this specification (including any accompanying claims, abstract, and drawings), and/or all of the steps of any method or process so disclosed, may be combined in any combination, except combinations where at least some of such features and/or steps are mutually exclusive. The invention is not restricted to the details of any foregoing aspects. The invention extends to any novel one, or any novel combination, of the features disclosed in this specification (including any accompanying claims, abstract, and drawings), or to any novel one, or any novel combination, of the steps of any method or process so disclosed.


As used in the specification and the appended claims, the singular forms “a,” “an” and “the” include plural referents unless the context clearly dictates otherwise. Ranges may be expressed herein as from “about” one particular value, and/or to “about” another particular value. When such a range is expressed, another aspect includes from the one particular value and/or to the other particular value. Similarly, when values are expressed as approximations, by use of the antecedent “about,” it will be understood that the particular value forms another aspect. It will be further understood that the endpoints of each of the ranges are significant both in relation to the other endpoint, and independently of the other endpoint. The terms “about” and “approximately” are defined as being “close to” as understood by one of ordinary skill in the art. In one non-limiting aspect the terms are defined to be within 10%. In another non-limiting aspect, the terms are defined to be within 5%. In still another non-limiting aspect, the terms are defined to be within 1%.


“Optional” or “optionally” means that the subsequently described event or circumstance may or may not occur, and that the description includes instances where said event or circumstance occurs and instances where it does not.


The terms “coupled,” “connected,” and the like as used herein mean the joining of two members directly or indirectly to one another. Such joining may be stationary (e.g., permanent) or moveable (e.g., removable or releasable). Such joining may be achieved with the two members or the two members and any additional intermediate members being integrally formed as a single unitary body with one another or with the two members or the two members and any additional intermediate members being attached to one another.


The terms “proximal” and “distal” as used herein refer to regions of the aspiration tubing or thrombectomy device. “Proximal” means a region closest to the practitioner during a procedure, while “distal” means a region farther from the practitioner during a procedure.


Throughout the description and claims of this specification, the word “comprise” and variations of the word, such as “comprising” and “comprises,” means “including but not limited to,” and is not intended to exclude, for example, other additives, components, integers or steps. “Exemplary” means “an example of” and is not intended to convey an indication of a preferred or ideal aspect. “Such as” is not used in a restrictive sense, but for explanatory purposes.


A vacuum is a pressure that is less than the local atmospheric pressure. As used herein, “vacuum pressure” indicates the relative pressure, i.e., the differential between ambient pressure and the absolute pressure applied by the vacuum. Thus, an increase in relative vacuum pressure is an increase in the difference between ambient pressure and the absolute vacuum pressure, which increases the force applied by the vacuum. Likewise, a decrease in relative vacuum pressure is a decrease in the difference between ambient pressure and the absolute vacuum pressure, which decreases the force applied by the vacuum.



FIGS. 1A-1D show an implementation of the thrombectomy device 1. FIG. 1A shows the aspiration catheter 106, the retrieval device 3, a collapsed braided assembly 102, and a guidewire tip 103. The aspiration catheter 106 is an elongated tube with reinforced construction that allows a vacuum to be applied at the proximal end to pull clot and emboli out of the artery or vein without collapsing. The aspiration catheter 106 can be formed of a polymer material. The aspiration catheter 106 can include an imaging marker 8 (such as a fluorescent or radiopaque marker) for use in imaging the position of the catheter during a procedure. Thrombus retrieval device 3 extends through aspiration catheter 106. The braided assembly 102 extends over a distal region 5 of the retrieval device 3, such that when the retrieval device 3 exits the distal end 7 of the aspiration catheter 106, the braided assembly 102 is positioned outside of the aspiration catheter 106. In the collapsed configuration, braided assembly 102 is sized and configured for insertion through the aspiration catheter 106 and into an artery or vein. Guidewire tip 103 extends distally from the distal end 107 of the retrieval device 3. The guidewire tip 103 can be flexible, shapeable, and steerable.


The braided assembly 102 is moveable from a collapsed to an expanded configuration. An example of a braided assembly 102 in an expanded configuration is shown in FIG. 1B, but the maximum diameter, dmax, of the expanded braided assembly 102 can be changed to any value over a continuous range, from a fully collapsed diameter, to a partially expanded diameter, to a fully expanded diameter. The maximum diameter of the braided assembly, dmax, is the widest point measured perpendicular to a longitudinal axis, a, extending through the center of the braided assembly 102. The braided assembly 102 can be sized and configured to disrupt and capture one or more clots, plaques, and/or thrombi and pull them toward the aspiration catheter 106 where they can be removed. The braided assembly 102 includes a braid 9, a slidable collar 108, and a fixed attachment point 101 where the braid 9 anchors to the retrieval device 3. The braid 9 may be attached directly to the retrieval device 3 at attachment point 101, or the braid 9 may be attached indirectly to the retrieval device 3 at attachment point 101. In some implementations, the fixed attachment point 101 is a fixed collar that extends around the retrieval device 3, and the braid is welded, bonded, or otherwise adhered to the fixed collar. Regardless, at the fixed attachment point 101, the braid 9 does not move longitudinally relative to the retrieval device 3.


The opposite end of braid 9 is welded, bonded, or otherwise adhered to slidable collar 108. In the implementations shown, the slidable collar 108 is slidably connected to the retrieval device 3 by virtue of its annular shape, which extends circumferentially around the retrieval device 3. The slidable collar 108 slides longitudinally along the retrieval device 3 as braid 9 is expanded and collapsed. The slidable collar 108 can be positioned distally to the fixed attachment point 101 (a distal position), as shown in FIGS. 1A-1C, or the slidable collar 108 can be positioned proximally to the fixed attachment point 101 (a proximal position). In some implementations, slidable collar 108 or fixed attachment point 101 can include a marker that can be viewed using imaging modalities during a procedure. For example, the slidable collar 108 or fixed attachment point 101 can include a fluorescent or radiopaque label.


The braid 9 is composed of multiple strands of wire. The braid 9 takes an elliptical or a spindle shape when expanded, having a maximum diameter dmax at or near the center of the braid 9 and narrowing as the braid approaches the fixed attachment point 101 and the slidable collar 108. The wires are formed of a shape memory material such as, but not limited to, shape memory polymers or shape memory metals (e.g., nitinol). The braid 9 has a baseline shape memory of the collapsed configuration, which forms a cylindrical structure around the retrieval device 3, as shown in FIG. 1A. In the activated, expanded configuration, the braid 9 has a tendency to relax toward the collapsed configuration.


When the practitioner is pulling a thrombus or plaque proximally toward aspiration catheter 106 using braided assembly 102, the braid 9 encounters distally oriented drag forces that are strongest along the widest portions (for example, the central region of the braid adjacent dmax). These drag forces resist the proximally oriented pulling force exerted by the practitioner. The distal end of braid 9 at slidable collar 108 will encounter less drag force while being pulled proximally because the radial force it exerts on the radially adjacent vasculature or thrombus is small, negligible, or non-existent. If the braid is not properly designed, the sliding collar 108 and distal end of the braid 9 will invert into the wider, central regions of the braid 9. Inversion during the procedure can be prevented by optimizing factors such as the pic count (crosses per inch), the wire diameter, the number of wires, and the ply of the braid (sets of overlapping braids). Higher pic counts increase flexibility, while lower pic counts increase longitudinal stiffness. Likewise, a braid with more than one ply (multiple sets of braids nested within each other), will be stiffer than a single-ply braid. Braids can be one-ply, two-ply, three-ply, or more. Braids with more wires will be stiffer than those with fewer wires, and braids with wider diameter wires will be stiffer than those with narrow diameter wires. Wires of varying diameters can be used within the same braid 9.


The design of the braided assemblies 102 disclosed herein may vary based on whether the device 1 is intended for an arterial procedure or for a venous procedure, since the procedure site will be wider in a venous setting. For example, a braid 9 designed for a venous application may have a dmax of from about 0.8 inches to 1.2 inches, including about 0.8 inches, about 0.9 inches, about 1.0 inch, about 1.1 inches, and about 1.2 inches. For venous applications, a braid 9 may have a wire diameter range from about 0.005 inches to about 0.02 inches, including 0.005 inches, 0.0075 inches, 0.01 inches, 0.0125 inches, 0.015 inches, 0.0175 inches, and 0.02 inches. Different wires of the braid 9 may have different diameters, or they may have the same diameter. In some venous implementations, the diameters of the wires of the braid 9 are 0.01 inches, 0.0125 inches, and/or 0.015 inches. Two-ply braids can utilize smaller wire diameters without sacrificing the radial force that can be applied. The pic count can be from 2 to 6 for venous applications. In some implementations used in venous applications, the pic count is 3, 4, or 5. The number of wires per braid for a venous application can be anywhere from 8 to 40, including 8, 16, 24, 32, and 40.


Braids for venous applications were tested using a selection of the above listed venous application parameters. End points included the expansion force and the radial outward force applied by the braid to the inner surface of a tubing that simulates a vein (the tubing having an inner diameter of 24 millimeters). The expansion force is the force required to open the braid, as applied to the activation wire. The data is shown below in Table 1.









TABLE 1







Prototype testing for braids used in venous applications















Wire

Maximum
Radial Outward





Diameter

Braid OD
Force in 24 mm
Expansion


Prototype
Braid Ply
(Inches)
# of Wires
(inches)
ID tube (N)
force (N)
















A
Double
0.008
16 per ply
1.0
4.4
2.5





(32 total)





B
Double
0.010
16 per ply
1.0
5.5-6.6
6





(32 total)





C
Single
0.0125
24
1.0
8.6-9.9
10









For arterial applications, the braid 9 can have dmax of from about 0.1 inches to about 0.4, including about 0.1 inches, about 0.12 inches, about 0.14 inches, about 0.18 inches, about 0.2 inches, about 0.22 inches, about 0.24 inches, about 0.28 inches, about 0.3 inches, about 0.32 inches, about 0.34 inches, about 0.36 inches, about 0.38 inches and about 0.4 inches. For example, the braid 9 can have a dmax of about 0.28 inches, 0.3 inches, or 0.31 inches. The diameter of the wires of the braid 9 for an arterial application can range from about 0.001 inches to about 0.007 inches, including about 0.001 inches, about 0.002 inches, about 0.003 inches, about 0.004 inches, about 0.005 inches, about 0.006 inches, and about 0.007 inches. Different wires of the braid 9 may have different diameters, or they may have the same diameter. In some arterial implementations, the diameters of the wires of braid 9 are 0.003 inches, 0.004 inches and/or 0.005 inches. Two-ply braids can utilize smaller wire diameters without sacrificing the radial force that can be applied. The pic count can be from 5 to 30 for arterial applications, including a pic count of 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 117, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29 and 30. In some implementations used in arterial applications, the pic count is 10, 12, or 15. The number of wires per braid 9 for an arterial application can be anywhere from 8 to 54, including 8, 16, 24, 32, 40, 48, and 54. In some implementations, the number of wires per braid 9 for an arterial application is 26, 24, or 30.


Braids for arterial applications were tested using a selection of the above listed arterial application parameters. End points included the radial outward force applied by the braid to the inner surface of a tubing (the tubing having an inner diameter of 6 millimeters), and the proximal force needed to pull the braid through a restriction in the tubing (the inner diameter of the restriction being 4 millimeters). The tubing and the restriction simulate an artery and a thrombus/plaque, respectively. Favorable prototypes give a high radial outward force without requiring excessive force to pull the braid through the restriction. The data is shown below in Table 2. All braids tested were one-ply.









TABLE 2







Prototype testing for braids used in arterial applications




















Radial







Profile

Outward
Force to pull






(Distal

Force applied
through 4 mm



Diameter


bond
Maximum
to 6 mm I.D.
ID



Wire
Pic
# of
OD)
Braid OD
tubing
Restriction


Prototype
(inches)
count
Wires
(inches)
(inches)
(Newtons)
(Newtons)

















A
0.004
10
16
0.050
0.28
0.8
1.8


B
0.004
15
24
0.053
0.28
1.0
2.8


C
0.005
10
16
0.054
0.31
1.5
3.2


D
0.005
10
24
0.058
0.31
1.6
4.1


E
0.006
10
16
0.060
0.31
1.7
4.4


F
0.006
12
16
0.063
0.30
1.8
4.6


G
0.002
24
48
0.073
0.31
0.8
1.9


H
0.003
24
48
0.078
0.31
1.8
3.5


I
0.004
12
24
0.054
0.31
1.9
2.6









The activation wire 105 extends through the lumen of the retrieval device 3, exits the retrieval device 3 at exit point 11, and extends distally along the exterior surface of the retrieval device 3. The distal end 13 of the activation wire 105 is attached to slidable collar 108. As such, the activation wire 105 is able to control the expansion and collapse of the braid 9 via the slidable collar 108. The distance between exit point 11 and slidable collar 108 affects the length that the slidable collar can be pulled along retrieval device 3 to open the braided assembly 102. If it is too close to slidable collar, the braided assembly 102 will not be able to open fully. As such, exit point 11 should be positioned proximally far enough from the unexpanded position of slidable collar 108 to enable the braided assembly 102 to open to its maximum outer diameter. FIG. 1C shows the implementation of FIGS. 1A and 1B without braid 9 to facilitate viewing the activation wire 105 and the activation wire exit point 11. FIG. 1D is a cross sectional view of activation wire 105 in retrieval device 3, taken at line A-A of FIG. 1C. The internal positioning of the proximal regions of the activation wire 105 (within retrieval device 3) is advantageous in that no friction or bulk is added by the system that controls expansion of the braided assembly 102.


The proximal region of activation wire 105 (not shown) may be tensioned and released to control the expansion and collapse of the braided assembly 102 via movement of slidable collar 108. Under tension, the activation wire 105 moves proximally within the lumen of the retrieval device 3 as it translates the tension from the proximal region of the activation wire 105 to the braided assembly 102. In implementations where the slidable collar 108 is in the distal position (as shown), the exit point 11 of the activation wire is located proximally to the slidable collar 108. The exit point 11 can be, for example, a portal in the sidewall of retrieval device 3. Use of a slidable collar 108 to expand the braided assembly 102 is advantageous because the distal end of the braided assembly 102 can be moved while the distal region 5 of the retrieval device 3 maintains a constant position within the vasculature. Maintaining a constant position of the distal region 5 of retrieval device 3 is advantageous because sliding proximal/distal movement of the distal region 5 within the vessel can result in vessel damage or perforation.


In implementations where the slidable collar 108 is in the proximal position relative to the fixed attachment point (not shown), the activation wire 105 extends distally past the slidable collar 108 inside the retrieval device 3, exits the retrieval device 3 at exit point 11, then doubles back and extends along the exterior surface of the retrieval device 3 to attach to the proximally located slidable collar 108. The exit point 11 can be a portal in the sidewall of the retrieval device as described above, or the exit point 11 can be the distal end 107 of the retrieval device 3.


Retrieval device 3 can include a proximal hypotube 100 and a distal support tube 104, as shown in FIG. 1C. In some implementations, the hypotube 100 extends through the support tube 104. However, the distal region can be made more flexible by attaching the proximal end of the distal support tube 104 to the distal end 17 of the proximal hypotube 100 (for example, by adhesive bonding, heat bonding, or welding processes). The fixed attachment point 101 of the braided assembly 102 can be located on distal support tube 104 and the slidable collar 108 can extend around the distal support tube 104, such that the braided assembly 102 is positioned over and around the distal support tube 104. The braided assembly 102 can alternatively be positioned only partially over the distal support tube (i.e., one of the fixed attachment point 101 or the slidable collar 108 is attached to the proximal hypotube 100, and the other of the fixed attachment point or the slidable collar 108 is attached to the distal support tube 104). In some implementations, the support tube 104 serves to increase the overall diameter of the retrieval device 3, for example, to accommodate a larger diameter braid and to encapsulate the guidewire tip 103. The distal support tube 104 can also provide a lower friction surface for movement of the slidable collar 108 than the proximal hypotube 100 would provide.


In some implementations, distal support tube 104 has greater flexibility than the proximal hypotube 100. For example, the distal support tube 104 can be made of a polymer material, while the proximal hypotube 100 is made of a more rigid metal material. In some implementations, the proximal hypotube 100 is constructed from metal hypodermic needle tubing. The hypotube 100 can be up to 50 times stiffer than the support tube 104. There are several advantages to having a distal support tube 104 with greater flexibility than proximal hypotube 100. The greater flexibility of the support tube 104 enables a gradual transition in flexibility between the hypotube 100 and the guidewire tip 103. In some scenarios, the greater flexibility of the distal support tube 104 can facilitate movement of the braided assembly 102 through a tortuous thrombus. The greater flexibility can promote kink resistance. The greater flexibility of the distal support tube 104 can also facilitate the introduction of a portal or exit point 11 during the production of the device. The higher rigidity of the hypotube 100 (as compared to support tube 104) is important because it allows the retrieval device 3 to be pushed through the vasculature. The rigidity of hypotube 100 also helps to ensure that the braided assembly 102 can be pushed through a thrombus or plaque.


On the proximal end, the activation wire 105 can be attached to a tensioning element (not shown) that allows the activation wire 105 to be moved forward or retracted backward within the retrieval device 3. Applying tension to the activation wire 105 causes the slidable collar 108 to move and causes the braided assembly 102 to expand to a diameter of the practitioner's choosing. Similarly, releasing tension on the activation wire 105 allows the braided assembly 102 to relax into the collapsed, baseline configuration.


In some implementations, such as the one shown in FIG. 2, the device includes a proximal handle 128. The handle 128 is coupled to a proximal end of retrieval device 3. The tensioning element is a knob 129 that is coupled to the proximal end of activation wire 105 on the inside of the handle. Actuation of the knob 129 in one direction causes the activation wire 105 to be tensioned (expanding the braided assembly), and actuation of the knob 129 in the opposite direction releases tension on the activation wire 105 (collapsing the braided assembly). In other implementations, the tensioning element can include a slider, ratcheting mechanism, or lever.


In some implementations, aspiration catheter 106 terminates in an adapter, such as adapter 204 shown in FIG. 13. The adapter 204 facilitates the connection of aspiration tubing 203, which can be connected to a vacuum system such as shown in FIG. 8 for removal of the clot or emboli. In some exemplary procedures, the distal end of retrieval device 3 is inserted axially through into the proximal end of adapter 204 (where shown using the arrow in FIG. 13). The retrieval device 3 is slid through the adapter 204 and subsequently through the aspiration catheter 106 until handle 128 abuts the proximal end of adapter 204.


Another implementation of a proximal handle 128 is shown in FIGS. 7A-7C. The handle 128 of FIGS. 7A-7C is advantageous in that it enables a practitioner to lock the braided assembly 102 at a fixed outer diameter. This can be useful, for example, when pushing and pulling the device through a thrombus. As shown in FIG. 7A, proximal handle 128 is coupled to a proximal end of retrieval device 3. Activation wire 105 extends proximally past the proximal end retrieval device 3 and into proximal handle 128. Strain relief section 139 is formed of a flexible material that prevents kinking of the retrieval device 3 just distal to the handle 128. Proximal handle 128 also includes a tensioning element in the form of locking slider 136, which slides proximally and distally within groove 138 and can be locked in place to secure the outer diameter of the braided assembly 102 during a procedure. The underside of locking slider 136 and groove 138 is shown in FIG. 7B, and a cross sectional view of locking slider and groove 138 is shown in FIG. 7C. Locking slider 136 includes a sliding portion 146 and a lock button 148. As seen in FIG. 7B, downward pointing teeth 140 extend downward from the inner surface 133 of the outer casing 135 of handle 128, from a position adjacent the groove 138. The lock button 148 includes an exterior portion 141 with a textured gripping surface. The lock button 148 extends downward through sliding portion 146, and includes an interior portion 137. The interior portion 137 of the lock button 148 extends away from the exterior portion 141 of lock button 148 in a direction that is perpendicular to the longitudinal axis A-A of the locking slider 136. Interior portion 137 includes upward facing teeth 142 that are configured to engage with the downward facing teeth 140 of the outer casing 135 of the handle 136. Spring 150, which is vertically positioned within slider 146, beneath the exterior surface 141 of lock button 148, exerts an upward force on lock button 148 to hold the upward facing teeth 142 in a locked configuration with the downward facing teeth 140 of the outer casing 135. When lock button 148 is compressed, the spring 150 is compressed and the teeth 140, 142 disengage. With the lock button 148 pressed and the teeth 140, 142 disengaged, proximal or distal force can be applied to sliding portion 146 to move the locking slider 136 within the groove 138. An interior portion 144 of the sliding portion 146 grips the activation wire 105. As the locking slider 136 is moved within groove 138, the activation wire 105 is moved proximally or distally to affect the expansion or allow the collapse of the braided assembly 102.


Conventional thrombectomy devices utilize shape memory elements with a baseline expanded configuration. These conventional devices risk inadvertent overexpansion and damage to the vessel. Furthermore, conventional devices are often restrained by a bulky overlying sheath, which is pulled back to allow the device to self-expand.


Advantageously, using a device with a shape memory of the collapsed position reduces the risk of overexpansion and injury during self-expansion. Self-collapse also allows the device to be restrained using the low-profile activation wire system described herein. An additional advantage is the ability to expand the braided assembly to various diameters to precisely custom fit the size of the vessel. This can be especially useful if the size of the vessel is different than originally anticipated. The level of grip between the braid 9 and the surrounding thrombus can also be customized as needed by applying different levels of tension to the activation wire 105. For example, the practitioner may apply a first level of tension to deploy the braided assembly 102 to a first expanded outer diameter to contact the thrombus. If the force between the thrombus and the braid 9 is not enough to pull the thrombus toward the aspiration catheter 106, the practitioner can widen the braid 9 to a second expanded outer diameter by applying a greater second level of tension to the activation wire 105. This widened diameter provides a greater contact force between the thrombus and the braid 9, such that the thrombus can be more easily pulled toward aspiration catheter 106.



FIGS. 3A-3D show an additional implementation of a thrombectomy device having a braided assembly 19 with multiple braided sections 111, 112. The elongated nature of this implementation facilitates the capture and retrieval of long thrombi. As shown in FIG. 3A and FIG. 3B, ach of the braided sections 111, 112 is attached to and extends around the distal region 22 of retrieval device 21. The braided assembly 19 includes multiple sliding collars 23, 25 and a fixed attachment point 27. Proximal braided section 111 is attached to and extends between the fixed attachment point 27 and the proximal slidable collar 23, where it is welded, bonded, or otherwise adhered at a central sliding attachment point 29. Distal braided section 112 is attached to and extends between the proximal slidable collar 23 and the distal slidable collar 25. In some implementations, the braided sections are formed by constraining one larger braid with the proximal slidable collar 23. In other implementations, each braided section is formed from a separate braid (such that each of the proximal and distal braided assemblies are separately fixedly attached to proximal slidable collar 23). In some implementations, the slidable collars 23, 25 can be positioned distally to the fixed attachment point 27, as illustrated in FIG. 3A. In other implementations, the slidable collars can be positioned proximally to the fixed attachment point (not shown). Though illustrated with two braided sections 111, 112, other implementations of the braided assembly 19 could include more than two braided sections and more than two slidable collars.



FIG. 3C shows the thrombectomy device of FIGS. 3A and 3B without the braided assembly 19. Retrieval device 21 has a hypotube 131 fixedly attached to a support tube 130. A single activation wire 132 extends through hypotube 131 and support tube 130 to an exit point 134 positioned on the support tube 130. From there, it travels along the outer surface of support tube 130, running beneath proximal sliding collar 23 to attach to distal sliding collar 25. Cross sectional views shown in FIG. 3D, FIG. 3E, FIG. 3F, and FIG. 3G show the radial position of activation wire 132 with respect to hypotube 131, the support tube 130, and the guidewire tip 103 at various axial locations along the thrombectomy device shown in FIG. 3C. The activation wire 132 is utilized to control expansion of the braided assembly via connection to the distal sliding collar 25. In other implementations, the activation wire 132 can be attached to the proximal sliding collar 23. Proximal movement of the proximal slidable collar 23 or the distal slidable collar 25 by the activation wire generates a force on the other of the two slidable collars, such that the two braided sections 111, 112 are expanded (or partially expanded) in unison. As described above, the braids are formed of a shape memory material with a bias toward the collapsed configuration, so that tensioning the activation wire enables multiple levels of expansion.



FIG. 4 shows an additional implementation with multiple, separately expandable braided assemblies 37, 39. The braided assemblies 37, 39 are spaced from each other along the distal region 32 of retrieval device 31. The proximal braided assembly 37 includes braided section 113 that extends between a fixed attachment point 33 and a slidable collar 115. The distal braided assembly 39 includes braided section 114 that extends between a fixed attachment point 35 and a slidable collar 116. Each braided assembly is controlled by a separate activation wire, such that each braided assembly can be individually controlled. Each activation wire exits the retrieval device 31 from an exit point beneath the individual braid and attaches to the individual slidable collar (not shown). The multiple activation wires can travel through the same lumen in retrieval device 31, or they could have individual lumens. Depending upon the positioning of the slidable collars in relation to the fixed attachment points, in some implementations, each additional activation wire can travel through the same lumen and exit the retrieval device at the same portal, or at different portals. In some implementations, one or more activation wires can exit from the distal end of the retrieval device 31.


As with the previously described implementations, the braids of the implementation shown in FIG. 4 are formed of a shape memory material with a bias toward the collapsed configuration, such that tensioning the activation wire enables deployment of the braid to a range of diameters. Each braided assembly is deployable to a partially expanded configuration by placing a first level of tension in the attached activation wire, or to a fully expanded configuration by placing a second, greater level of tension into the activation wire. Thus, when multiple activation wires and braided assemblies are used, a first braided assembly can be deployed to a partially expanded state while a second braided assembly is deployed in a fully expanded state. In some scenarios, it may be advantageous for one braided assembly to be fully collapsed while another braided assembly is either partially or fully expanded. This can be advantageous, for example, when pulling a longer thrombus into the aspiration catheter 106. The proximal braided section 113 can be collapsed as it enters the aspiration catheter, prior to the distal braided section 114 which is still outside of the aspiration catheter.


In some implementations, braids of separate braided sections or separate braided assemblies can have different properties, such as different maximum expanded diameters, different wire sizes, different wire densities, different numbers of wires, etc. These properties can vary depending upon the positioning of the braided section or the braided assembly along the retrieval device. For example, the distal braided section or braided assembly might have a larger expanded diameter to better pull back against the thrombus, while the proximal braided section(s) or braided assembly(s) might be less dense and stronger to better engage the middle of the thrombus.



FIGS. 5A-5C show an implementation of the thrombectomy device that enables use with a guidewire, such that a practitioner can remove and reinsert the device to the same anatomic position multiple times (for example, to clean the device during the procedure). FIG. 5A shows aspiration catheter 127, retrieval device 121, guidewire tubing 118, braided assembly 123 (in the collapsed configuration), and guidewire 45. Guidewire tubing 118 is positioned around the distal region 61 of retrieval device 121. The guidewire tubing 118 is shorter than the retrieval device 121 in the longitudinal direction, such that the guidewire 45 leaves the guidewire tubing 118 at the proximal guidewire exit 117 and extends alongside retrieval device in a proximal direction. FIG. 5B shows the implementation of FIG. 5A with the braided assembly 123 in an expanded state. As shown in the cross section of FIG. 5C taken at line B-B of FIG. 5B, guidewire 45 extends through the first lumen 124 of the guidewire tubing 118. The guidewire 45 exits guidewire tubing 118 at distal guidewire exit 47. The guidewire tubing 118 can include a distal atraumatic tip 120. The guidewire tubing 118 can be formed, for example, of a polymer material. Retrieval device 121, including activation wire 125, extends through a second lumen 126 of the guidewire tubing 118. As described above, the activation wire 125 is connected on the proximal end to a tensioning element, extends through retrieval device 121 to an exit point, leaves the retrieval device 121 at the exit point (beneath the braid), and attaches at its distal end to the slidable distal collar 122 on the braided assembly 123. The exit point can be, for example, a tunnel through the sidewalls of the retrieval device 121 and the guidewire tubing 118 (i.e., a tunnel formed by a portal in the sidewall of the retrieval device 121 that is aligned/coaxial with a portal in the sidewall of the guidewire tubing 118). In use, the guidewire tubing 118 and the retrieval device 121 are introduced together over the previously placed vascular guidewire 45. Because the guidewire 45 is retained within the guidewire tubing 118, it is pulled at least partially to the side within the lumen of aspiration catheter 127 and can move without interfering with activation wire 125. The guidewire tubing 118 and the retrieval device 121 keep the activation wire 125 and the guidewire 45 moving in an axial direction, independently from one another, using a low-profile and low-friction design. Once in position, the braided assembly 123 is expanded and the proximal end of the aspiration catheter 127 is connected to a vacuum source. The braided assembly 123 is expanded and then retracted back toward the aspiration catheter 127, pulling the clot with it and breaking it into small pieces.


Methods of performing thrombectomy procedures are also disclosed herein. An example method is illustrated in FIGS. 6A-6F. FIG. 6A illustrates thrombus 49 occluding vessel 51. Distal end of aspiration catheter 53 is advanced through the vasculature to an area proximal to the thrombus 49, as shown in FIG. 6B. The distal end of retrieval device 55 carrying braided assembly 57 is advanced out the distal end of the aspiration catheter 53 and through thrombus 49, such that the braided assembly 57 is distal to thrombus 49, as shown in FIG. 6C. The practitioner then places tension in the activation wire housed inside the retrieval device 55, thereby moving the activation wire longitudinally within the lumen of the retrieval device and moving the slidable collar of the braided assembly longitudinally over the exterior surface of the retrieval device. Movement of the slidable collar via the activation wire causes braided assembly 57 to expand to the diameter of the practitioner's choosing. Should the practitioner wish to alter the level of expansion during the procedure (i.e., change the maximum diameter d of the braided assembly 57), this is made possible by altering the level of tension in the activation wire, which again moves the activation wire within the retrieval device and moves the slidable collar, as described above. Advantageously, the distal end of the retrieval device 55 maintains a stationary position as the braided assembly is expanded to the optimal diameter. Maintaining a constant position of the distal end of retrieval device 55 is advantageous because sliding proximal/distal movement of the distal end within the vessel can result in vessel damage or perforation.



FIG. 6D shows the braided assembly 57 in an expanded configuration, sized to fit the vessel 51. The practitioner then pulls the retrieval device 55 proximally and contacts the thrombus 49 with the braided assembly 57, as shown in FIG. 6E. The thrombus 49 and braided assembly 57 are pulled proximally toward aspiration catheter 53. The aspiration catheter 53 can be connected to an external vacuum source (not shown), which enables the aspiration of the thrombus 49 into the distal end of the aspiration catheter 53. The aspiration catheter 53 is then retracted proximally, as illustrated in FIG. 6F, and removed from the body.


The ability to open the braided assembly to a range of different diameters is useful to thrombectomy procedures for multiple reasons and in multiple scenarios. The ability to custom fit the braid to a particular vessel during the procedure is preferable over introducing a braid that expands to a predetermined size, then discovering mid-procedure that it is either too small to grip the thrombus or that it is too large and has damaged the vessel. As another exemplary advantage, the level of grip between the braid and the thrombus can be optimized mid-procedure. For example, the practitioner may apply a first level of tension to the activation wire to deploy the braided assembly to a first expanded outer diameter to contact the thrombus. If the force between the thrombus and the braid is not sufficient to pull the thrombus toward the aspiration catheter, the practitioner can widen the braid to a second expanded outer diameter by applying a greater second level of tension to the activation wire. This widened diameter increases the contact force between the thrombus and the braid, such that the thrombus is more easily pulled toward aspiration catheter.


The methods can also be performed using a guidewire. For example, the guidewire can be positioned distal to the thrombus prior to advancing the distal end of the retrieval device. The retrieval device extends at least partially through a lumen of the guidewire tubing, such as in the implementation of FIGS. 5A-5C. Together, the retrieval device and guidewire tubing are advanced over the guidewire and toward the thrombus. The guidewire extends through a separate lumen of the guidewire tubing than the retrieval device and activation wire. Once positioned, the activation wire is moved longitudinally within the retrieval device to expand the braided assembly.


Long thrombi can be addressed using braided assemblies with multiple braided sections such as the implementation shown in FIG. 3. Movement of the slidable collar results in expansion of more than one of the braided sections, resulting in a relatively long braided assembly. In some implementations a device with multiple, separately expandable braided assemblies, such as the one shown in FIG. 4, can be used to treat long thrombi. With separately expandable braided assemblies, as the thrombus is drawn proximally closer to the distal end of the aspiration catheter, the proximally positioned braided assembly collapses from a first expanded outer diameter to the collapsed diameter (or to a narrower second expanded outer diameter). The distally positioned braided assembly maintains an expanded outer diameter that is greater than the outer diameter of the proximally positioned braided assembly until it too is pulled into the aspiration catheter.


The aspiration systems and methods disclosed herein are configured to control blood loss during thrombus removal. An example aspiration system 201 is shown in FIG. 8. The aspiration system 201 includes an aspiration tubing 203, which extends from adapter 204 shown in FIG. 13. An aspiration lumen 216 extends from (and includes) the lumen of the aspiration catheter 106 and the lumen of the aspiration tubing 203 leading to the receptacle 205. The aspiration tubing 203 is coupled to a receptacle 205 for collecting liquid aspirated by the aspiration catheter 106. In other implementations, aspiration catheter 106 can be directly coupled to receptacle 205 for collecting liquid aspirated by the aspiration catheter 106. The aspiration tubing 203 (or aspiration catheter 106) creates a fluidic seal with the receptacle 205, and a vacuum line 207 is also fluidically coupled to and sealed with receptacle 205. The vacuum line 207 is fluidically coupled to a vacuum pump 209.


The aspiration tubing 203 is coupled to one or more sensors 211. (If aspiration catheter 106 is directly attached to receptacle 205, the sensors 211 are coupled to the catheter 106.) A sensor 211 is configured to measure a flow parameter associated with a liquid within the lumen of the aspiration tubing 203 (such as the flow rate, for example). The sensor 211 is operably connected to a vacuum controller 213, for example, via wiring 215 to 4-pin connector 217 (or any suitable connector). The vacuum controller 213 is also operably coupled to a regulator 219, for example, via wiring 220, and regulator 219 is coupled to vacuum line 207. The regulator 219 is configured to adjust the vacuum pressure within the vacuum line 207.


When the vacuum controller 213 receives the flow parameter from sensor 211, it compares the flow parameter to a desired target range and sends an automatic control signal to the regulator 219, based on the comparison of the flow parameter to the target range. The automatic control signal causes the regulator 219 to adjust the vacuum pressure within vacuum line 207. For example, the automatic control signal can cause the regulator 219 to reduce the vacuum pressure upon a determination that the flow parameter is above an upper limit of the target range, or to decrease the vacuum pressure upon a determination that the flow parameter is below a lower limit of the target range. The vacuum controller 213 and the regulator 219 can optionally communicate in a feedback loop to regulate the vacuum pressure, wherein the vacuum controller 213 communicates a control signal to the regulator 219 and the regulator 219 communicates the current vacuum pressure back to the vacuum controller 213. In one example, communication from the regulator 219 to the vacuum controller 213 can be accomplished via wiring 221. These components and operations will be discussed in greater detail, below.


The vacuum pump 209 can be a standard medical suction pump conventionally used in hospitals, outpatient surgery centers, and clinical practices. As one example, the vacuum pump 209 can be a Basic Suction Pump (Medela AG, Baar, Switzerland), which has piston-cylinder based drive unit and mechanical overflow to protect the pump. The Medela Basic Suction pump has a max flow rate of 300 mL/min and a maximum vacuum of 90 kPa below ambient pressure. However, the make or model of vacuum pump 209 is not limited—it can be any type available in clinical settings. The vacuum pump 209 can be provided by the user, or it can be provided as part of a kit with some or all of the other components shown in FIG. 8.


The aspiration tubing 203 is coupled to the receptacle 205 at an intake port 223, and the vacuum line 207 is coupled to the receptacle 205 at the vacuum port 225. The aspiration tubing 203, receptacle 205, and vacuum line 207 can be any make or model. The sizes and materials can be adapted to suit the needs of the particular procedure. These components can be provided by the user, or they can be provided as part of a kit with some or all of the other components shown in FIG. 8. The components shown on the right side of the arrows in FIG. 8, including the aspiration tubing 203, the flow sensor 211, the receptacle 205 and the vacuum line 207 can all optionally be disposable to reduce the need for sterilization between procedures. A connector 227 can be placed on the vacuum line 207 to enable connection of the disposal portion 207a of the vacuum line with a reusable portion 207b of the vacuum line.


As discussed above, regulator 219 communicates with vacuum controller 213 to control the pressure in vacuum line 207. In one example, the regulator is an ITC 2090. As one example, the regulator 219 include can have a valve that opens the vacuum line 207 to the atmosphere, thus decreasing the vacuum pressure by venting the system. As another example, regulation of flow can be achieved by incorporating an adjustable flow valve, which may widen or narrow the vacuum line 207b to alter the flow capacity (i.e., direct flow control). Notably, handling flow adjustments on the vacuum side (i.e., to the left of the arrow in FIG. 8) reduces the need to clean the flow handling components. This is an advantage over systems with components that physically restrict blood flow within the aspiration tubing.


The flow sensor 211 can be in direct contact with the liquid in the aspiration tubing 203, or it can be configured for contactless sensing. For example, in some implementations, the flow sensor 211 is a paddle-wheel style sensor positioned within the aspiration lumen 216. A paddle-wheel style sensor sends turn frequency measurements to the vacuum controller 213, which determines the flow rate accordingly. Alternatively, the flow sensor 211 can be an ultrasonic sensor, a laser-based sensor, an infrared sensor, or some other optical based sensor, measuring the flow parameters through the walls of aspiration tubing 203 without contacting the blood. These have the benefit of being reusable, but are typically costlier than a contact-based sensor. While a single sensor 211 is shown in FIG. 8, it is further possible to incorporate a plurality of sensors that measure at disparate points along a length of the aspiration tubing 203. In some examples, an interfacing filter can be positioned upstream from the flow sensor 211 to filter clots before they reach the sensor.


Adapter 204 shown in FIG. 13 facilitates the entry of the retrieval device 3 through proximal port 206 and into the lumen of the aspiration catheter 106. Adapter 204 also provides a fluidic coupling between the aspiration catheter 106 and vacuum system 201 (via aspiration tubing 203). Infusion port 208 allows for the introduction of saline or other infusion fluids. Adapter 204 houses an airtight valve that enables retrieval device 3 to be introduced through proximal port 206 without passing air into the adapter 204. However, the aspiration tubing 203 can include an air leak sensor 214, such as an optical sensor, to detect air passage in case of valve failure. In some implementations, the air leak sensor 214 is positioned proximal to the flow sensor 211 to detect air before it reaches the vacuum system. Alternatively, the air leak sensor 214 can be integral with the flow sensor 211.


The air leak sensor 214 can communicate a leak signal to the vacuum controller 213, the regulator 219, or directly to the vacuum pump 209, at which point the vacuum controller 213, the regulator 219, or the pump 209 slows or stops the vacuum flow while the air leak is addressed, reducing blood loss. In some implementations, there is a leak detection delay during initialization of the vacuum. The leak detection delay prevents the aspiration of the initial air in the tube—otherwise, the air leak sensor may detect it as a leak.


As shown in FIG. 8, the flow sensor 211 can be in communication with an indicator 212. The indicator 212 can be configured to inform the user of a characteristic of the flow parameter or flow rate. For example, the indicator 212 can be an LED light or an LED light panel, with variations in luminosity or flashing frequency that indicate the flow rate through the aspiration tubing 203. The indicator could alternatively be audible, or it could be a display on a user interface 229. The indicator 212 is shown positioned on the flow sensor 211, but in operation could be positioned anywhere within the system. The flow sensor 211 can communicate directly with the indicator 212, or via the vacuum controller 213.


The system provide for one or more manual override options, which may communicate a complete shut-off of the vacuum or aspiration flow, a scaled diminishing of the vacuum or aspiration flow, a reactivation of vacuum or aspiration flow, or a scaled increasing of the vacuum or aspiration flow. The manual commands are accepted at one or more manual inputs, such as, but not limited to, clamps, switches, buttons, sliders, knobs, pedals or a digital user interface. In some examples, a clamp 231 can be coupled to the aspiration tubing 203 to enable the practitioner to manually stop the flow of blood through the aspiration tubing 203, overriding the automated system. Alternatively or additionally, a manual override switch or button can communicate with the regulator 219 to fully open the valve to atmospheric pressure, thereby releasing the pressure in the vacuum line 207. As an alternative to a binary switch or button that fully releases the vacuum, sliders, knobs, or the like can be used to diminish or increase the vacuum force gradually. As another alternative, a foot pedal (not shown) can be activated to shut down or slow the flow either at the clamp 231, the regulator 219, or the pump 209 (or reactivate and increase the flow at any of those components). In some implementations, a manual override option can be provided at a user interface 229 (including manual or digital switches, sliders or knobs). Finally, the user has the option to turn the vacuum on and off at the vacuum pump 209, or gradually adjust its strength.


Triggering a manual override option can induce a first manual control signal to be sent from the manual input to the vacuum controller. The first manual control signal can cause the vacuum controller 213 to stop performing the step of comparing the flow parameter to the target range, or to stop the step of forming the automatic control signal, or to stop the step of sending the automatic control signal to the regulator. The vacuum controller 213 can instead send a second manual control signal to the regulator 219 based on the manual input (information from the first manual control signal). Alternatively, triggering a manual override option can send a manual control signal from the manual input directly to the regulator 219 to raise or lower the vacuum pressure in the vacuum line 207. Likewise, the manual input can be triggered to reactivate any or all of these processes.


In some implementations, the receptacle 205 can include a receptacle vent 210 in communication with the vacuum controller 213, the vacuum pump 209, the regulator 219, or with one or more of the manual inputs. Any one of the above-listed manual override actions can trigger a receptacle venting signal to be sent to the receptacle vent 210, directly or via the vacuum controller 213. The vent receives the receptacle venting signal and opens to equilibrate the pressure in the receptacle 205 with atmospheric pressure. This action eliminates residual pressure in the receptacle 205 that might otherwise cause the suction of additional blood after the manual override action. In some aspects, the venting signal may be a manual control signal sent by the vacuum controller 213 or regulator 219 upon activation of one or more manual inputs (for example, a manual command to override the vacuum system).


The clamp 231 can be coupled to tubing between the aspiration tubing 203 and the receptacle 205 and can be activated by a switch 233 for ease of use. The switch 233 can have an open configuration and a closed configuration. In the closed configuration, the switch tells the clamp 231 to close off the flow to the receptacle 205. In the open configuration, the switch 233 tells the clamp 231 to open the catheter 203 and allow blood to flow into receptacle 205. However, closure of clamp 231 can cause vacuum pressure to build up in the vacuum line 207. Opening the clamp 231 can thus cause a sudden surge and suction of blood. To avoid this, the switch 233 can be in operable communication with either the vacuum controller 213 or the regulator 219 (for example, via wiring 235). The shifting of switch 233 to the open configuration sends a surge signal to the regulator 219, either directly or via vacuum controller 213 as shown in FIG. 8. The surge signal causes the regulator to decrease the vacuum pressure in vacuum line 207, thereby reducing the surge of blood associated with opening the clamp 231. In some examples, the switch can be configured to cause a lowering of the vacuum pressure in the vacuum line 207 before releasing the clamp 231.


Some examples of the system include a user interface 229. The user interface 229 can optionally be a touch screen, or it can be in communication with a keyboard. Regardless, the user interface can be configured to accept manual input. The user interface 229 can be in communication with the vacuum controller 213 or with the regulator 219, and is configured to send manual control signals to the vacuum controller 213 or the regulator 219 responsive to the manual input. For example, the user can adjust the upper and lower limits of the target range and/or the time delay in triggering a vacuum change (for example, how long the flow rate is permitted to be at or above the upper limit before the vacuum pressure is decreased). The user interface can include a manual override button that allows the user to stop automated control and manually set the flow rate through the aspiration tubing 203. The user interface 229 can also include readouts to inform the user of the instantaneous flow rate through the aspiration tubing 203, and/or the total blood collected at receptacle 205.


Communication between the components of aspiration system 201 can take occur via any suitable communication link that facilitates data exchange between the components. Communication links can include wired, wireless, and optical links. Example communication links include, but are not limited to, a local area network (LAN), a wireless local area network (WLAN), a wide area network (WAN), a metropolitan area network (MAN), Ethernet, the internet, or any other wired, or wireless link such as WiFi, WiMax, 3G, 4G, or 5G. As shown in FIG. 8, the communication links can be formed of electrical or optical wires 215, 220, 221, 235, and 237. However, the presence of some wires in the drawing is not intended to indicate that those communication links, or any communication links, within the system must be hard-wired. Any of the communication links disclosed herein can be wired or wireless in nature.


The vacuum controller 213 can advantageously be a microprocessor that operates independently of a larger computer system. For example, vacuum controller 213 can be a complex instruction set microprocessor, a reduced instruction set microprocessor, a superscalar processor, an application specific integrated circuit, or a digital signal multiprocessor. The vacuum controller 213 is configured to measure frequency from the flow parameter received from sensor 211, and includes an analog to digital converter and a digital to analog converter. Power source 239 can be any suitable power source, and can be external to the vacuum controller 213 (such as a wall outlet) or internal to the vacuum controller 213 (such as a battery).


In some implementations, power sensors 240 can be included on the pump 209 and/or the vacuum controller 213 in order to synchronize the delivery of power between the two components. That is, when one of the two components (pump 209 or vacuum controller 213) is powered off, the power sensor 240 on the other of the two components detects the power change and is automatically powered off. Likewise, when one of the two components (pump 209 or vacuum controller 213) is powered on, the other is also automatically powered on.


With the basic structure of the aspiration system 201 being thusly disclosed, a greater appreciation of the construction and benefits of may be gained from the following discussion of the operation of the aspiration system 201 as shown in the flow chart at FIG. 9 and in reference to the diagram of FIG. 8. It is to be noted that this discussion is provided for illustrative purposes only. A method of controlling blood loss during thrombus removal is disclosed herein. The method includes first positioning an aspiration tubing 203 within the vascular system of a subject. The vacuum pump 209 is then initialized, or activated (either directly or via power sensor 240 which is in communication with the power supply to vacuum controller 213). The vacuum pump 209 is in fluid communication with the aspiration tubing 203. The method further includes initiating a flow of blood through an aspiration lumen 216 and measuring a flow parameter of the blood within the aspiration lumen 216 using a flow sensor 211. The method further includes receiving the flow parameter from flow sensor 211 at a vacuum controller 213. The vacuum controller 213 compares the flow parameter to a target range for the flow parameter and sends an automatic control signal to the vacuum regulator 219 based on a comparison of the flow parameter to the target range. The method further includes adjusting the vacuum pressure within the vacuum line 207 according to information stored in the automatic control signal.


In some example methods, activating a vacuum pump comprises activating the vacuum pump at full power, as shown in FIG. 9. Full vacuum power is fed to the regulator 219, which is regulated by the vacuum controller 213. When the flow exceeds the upper limit, the vacuum pump can be dropped off full power, and a finer level of intermediate control can be commanded via the regulator. The regulator can vent the system to atmospheric pressure to the extent necessary to accomplish the desired intermediate vacuum level.


The vacuum is imposed on the catheter 203 through the receptacle 205. The catheter 203 draws fluid from the patient. The flow is measured and a closed circuit loop is formed that provides controlling the desired flow with the amount of vacuum. When the flow drops below the lower limit, the vacuum controller 213 returns the vacuum pump 209 to full power and commands the regulator to fully close the system to atmospheric pressure.


For example, FIG. 10 shows a line graph of the flow rate in aspiration tubing 203. At initialization, the vacuum is increased to full power and flow rate reaches the first peak seen on the graph—the upper limit (uppermost dashed horizontal line). The vacuum controller 213 determines that the upper limit of the flow rate has been reached, and controller tells the regulator 219 to reduce the pressure in the vacuum line 207. The vacuum controller 213 continues to tell the regulator 219 to reduce vacuum pressure until the flow rate reaches the intermediate level (middle horizontal dashed peak). The flow rate continues at the intermediate level until it is reduced by the presence of a clot. The reduction of flow rate down to the lower limit (lowermost dashed horizontal line) causes the vacuum controller 213 to tell the regulator 219 to enable allow full vacuum power in the vacuum line 207, and the flow rate again reaches the upper limit.


Adjusting the vacuum pressure can be accomplished by decreasing the vacuum pressure upon a determination that the flow parameter is above an upper limit of the target range. In some examples, the upper limit is a flow rate of from 70 mL per minute to 130 mL per minute (including, for example, 70 mL per minute, 75 mL per minute, 80 mL per minute, 85 mL per minute, 90 mL per minute, 95 mL per minute, 100 mL per minute, 105 mL per minute, 110 mL per minute, 115 mL per minute, 120 mL per minute, 125 mL per minute, and 130 mL per minute).


In some example methods, the vacuum pressure is decreased until the measured flow parameter reaches an intermediate level flow rate of from 20 mL per minute to 50 mL per minute (including, for example, 20 mL per minute, 25 mL per minute, 30 mL per minute, 35 mL per minute, 40 mL per minute, 45 mL per minute, and 50 mL per minute).


Adjusting the vacuum pressure can be accomplished by increasing the vacuum pressure upon a determination that the flow parameter is below a lower limit of the target range. The lower limit can be, for example, from 0 mL per minute to 50 mL per minute (including, for example, 0 mL per minute, 10 mL per minute, 15 mL per minute, 20 mL per minute, 25 mL per minute, 30 mL per minute, 35 mL per minute, 40 mL per minute, 45 mL per minute, and 50 mL per minute).


In some implementations, decreasing or increasing the vacuum pressure can occur gradually, or in a stepwise manner, according to an aspiration program. This helps to reduce sudden surges and stops, giving the practitioner sufficient time to respond as necessary to sudden changes in flow rate. For example, FIG. 11, shows a line graph where flow rate is decreased in a step wise manner. At initialization, the vacuum is increased to full power and flow rate reaches the first peak seen on the graph—the upper limit of 100 mL per minute in this example (uppermost dashed horizontal line). The vacuum controller 213 determines that the upper limit of the flow rate has been reached, and vacuum controller 213 tells the regulator 219 to reduce the pressure in the vacuum line 207 to a first intermediate flow rate of 75 mL per minute (in this example). The vacuum controller 213 operates the regulator 219 at this first intermediate level for a specified time period and then tells the regulator to decrease the flow rate to a second intermediate level—50 mL per minute in this example. The vacuum controller 213 operates the regulator at this second intermediate level for a specified time period and then tells the regulator to decrease the flow rate to a third intermediate level—20 mL per minute in this example. The flow rate continues at the third intermediate level until it is reduced by the presence of a clot. The reduction of flow rate down to the lower limit (lowermost dashed horizontal line—5 mL per minute in this example) causes the vacuum controller 213 to tell the regulator 219 to enable allow full vacuum power in the vacuum line 207, and the flow rate again reaches the upper limit.


In some implementations, the durations of time in each of the steps of the aspiration program shown in FIG. 11 can be programmable via a manual input such as those described above. The user can set the duration of the “burst” (full vacuum power) and of each stepwise interval via a slider, a knob, a user interface, the software, or a combination thereof. The user can thus tailor the aspiration program to the procedural situation.


It should be appreciated that the logical operations described herein with respect to the various figures may be implemented (1) as a sequence of computer implemented acts or program modules (i.e., software) running on a computing device (e.g., the computing device described in FIG. 12), (2) as interconnected machine logic circuits or circuit modules (i.e., hardware) within the computing device and/or (3) a combination of software and hardware of the computing device. Thus, the logical operations discussed herein are not limited to any specific combination of hardware and software. The implementation is a matter of choice dependent on the performance and other requirements of the computing device. Accordingly, the logical operations described herein are referred to variously as operations, structural devices, acts, or modules. These operations, structural devices, acts and modules may be implemented in software, in firmware, in special purpose digital logic, and any combination thereof. It should also be appreciated that more or fewer operations may be performed than shown in the figures and described herein. These operations may also be performed in a different order than those described herein.


Referring to FIG. 12, an example computing device 900 upon which implementations of the invention may be implemented is illustrated. For example, the vacuum controller 213 may each be implemented as a computing device, such as computing device 900. It should be understood that the example computing device 900 is only one example of a suitable computing environment upon which implementations of the invention may be implemented. Optionally, the computing device 900 can be a well-known computing system including, but not limited to, personal computers, servers, handheld or laptop devices, multiprocessor systems, microprocessor-based systems, network personal computers (PCs), minicomputers, mainframe computers, embedded systems, and/or distributed computing environments including a plurality of any of the above systems or devices. Distributed computing environments enable remote computing devices, which are connected to a communication network or other data transmission medium, to perform various tasks. In the distributed computing environment, the program modules, applications, and other data may be stored on local and/or remote computer storage media.


In an implementation, the computing device 900 may comprise two or more computers in communication with each other that collaborate to perform a task. For example, but not by way of limitation, an application may be partitioned in such a way as to permit concurrent and/or parallel processing of the instructions of the application. Alternatively, the data processed by the application may be partitioned in such a way as to permit concurrent and/or parallel processing of different portions of a data set by the two or more computers. In an implementation, virtualization software may be employed by the computing device 900 to provide the functionality of a number of servers that is not directly bound to the number of computers in the computing device 900. For example, virtualization software may provide twenty virtual servers on four physical computers. In an implementation, the functionality disclosed above may be provided by executing the application and/or applications in a cloud computing environment. Cloud computing may comprise providing computing services via a network connection using dynamically scalable computing resources. Cloud computing may be supported, at least in part, by virtualization software. A cloud computing environment may be established by an enterprise and/or may be hired on an as-needed basis from a third party provider. Some cloud computing environments may comprise cloud computing resources owned and operated by the enterprise as well as cloud computing resources hired and/or leased from a third party provider.


In its most basic configuration, computing device 900 typically includes at least one processing unit 920 and system memory 930. Depending on the exact configuration and type of computing device, system memory 930 may be volatile (such as random access memory (RAM)), non-volatile (such as read-only memory (ROM), flash memory, etc.), or some combination of the two. This most basic configuration is illustrated in FIG. 12 by dashed line 910. The processing unit 920 may be a standard programmable processor that performs arithmetic and logic operations necessary for operation of the computing device 900. While only one processing unit 920 is shown, multiple processors may be present. Thus, while instructions may be discussed as executed by a processor, the instructions may be executed simultaneously, serially, or otherwise executed by one or multiple processors. The computing device 900 may also include a bus or other communication mechanism for communicating information among various components of the computing device 900.


Computing device 900 may have additional features/functionality. For example, computing device 900 may include additional storage such as removable storage 940 and non-removable storage 950 including, but not limited to, magnetic or optical disks or tapes. Computing device 900 may also contain network connection(s) 980 that allow the device to communicate with other devices such as over the communication pathways described herein. The network connection(s) 980 may take the form of modems, modem banks, Ethernet cards, universal serial bus (USB) interface cards, serial interfaces, token ring cards, fiber distributed data interface (FDDI) cards, wireless local area network (WLAN) cards, radio transceiver cards such as code division multiple access (CDMA), global system for mobile communications (GSM), long-term evolution (LTE), worldwide interoperability for microwave access (WiMAX), and/or other air interface protocol radio transceiver cards, and other well-known network devices. Computing device 900 may also have input device(s) 970 such as a keyboards, keypads, switches, dials, mice, track balls, touch screens, voice recognizers, card readers, paper tape readers, or other well-known input devices. Output device(s) 960 such as a printers, video monitors, liquid crystal displays (LCDs), touch screen displays, displays, speakers, etc. may also be included. The additional devices may be connected to the bus in order to facilitate communication of data among the components of the computing device 900. All these devices are well known in the art and need not be discussed at length here.


The processing unit 920 may be configured to execute program code encoded in tangible, computer-readable media. Tangible, computer-readable media refers to any media that is capable of providing data that causes the computing device 900 (i.e., a machine) to operate in a particular fashion. Various computer-readable media may be utilized to provide instructions to the processing unit 920 for execution. Example tangible, computer-readable media may include, but is not limited to, volatile media, non-volatile media, removable media and non-removable media implemented in any method or technology for storage of information such as computer readable instructions, data structures, program modules or other data. System memory 930, removable storage 940, and non-removable storage 950 are all examples of tangible, computer storage media. Example tangible, computer-readable recording media include, but are not limited to, an integrated circuit (e.g., field-programmable gate array or application-specific IC), a hard disk, an optical disk, a magneto-optical disk, a floppy disk, a magnetic tape, a holographic storage medium, a solid-state device, RAM, ROM, electrically erasable program read-only memory (EEPROM), flash memory or other memory technology, CD-ROM, digital versatile disks (DVD) or other optical storage, magnetic cassettes, magnetic tape, magnetic disk storage or other magnetic storage devices.


It is fundamental to the electrical engineering and software engineering arts that functionality that can be implemented by loading executable software into a computer can be converted to a hardware implementation by well-known design rules. Decisions between implementing a concept in software versus hardware typically hinge on considerations of stability of the design and numbers of units to be produced rather than any issues involved in translating from the software domain to the hardware domain. Generally, a design that is still subject to frequent change may be preferred to be implemented in software, because re-spinning a hardware implementation is more expensive than re-spinning a software design. Generally, a design that is stable that will be produced in large volume may be preferred to be implemented in hardware, for example in an application specific integrated circuit (ASIC), because for large production runs the hardware implementation may be less expensive than the software implementation. Often a design may be developed and tested in a software form and later transformed, by well-known design rules, to an equivalent hardware implementation in an application specific integrated circuit that hardwires the instructions of the software. In the same manner as a machine controlled by a new ASIC is a particular machine or apparatus, likewise a computer that has been programmed and/or loaded with executable instructions may be viewed as a particular machine or apparatus.


In an example implementation, the processing unit 920 may execute program code stored in the system memory 930. For example, the bus may carry data to the system memory 930, from which the processing unit 920 receives and executes instructions. The data received by the system memory 930 may optionally be stored on the removable storage 940 or the non-removable storage 950 before or after execution by the processing unit 920.


It should be understood that the various techniques described herein may be implemented in connection with hardware or software or, where appropriate, with a combination thereof. Thus, the methods and apparatuses of the presently disclosed subject matter, or certain aspects or portions thereof, may take the form of program code (i.e., instructions) embodied in tangible media, such as floppy diskettes, CD-ROMs, hard drives, or any other machine-readable storage medium wherein, when the program code is loaded into and executed by a machine, such as a computing device, the machine becomes an apparatus for practicing the presently disclosed subject matter. In the case of program code execution on programmable computers, the computing device generally includes a processor, a storage medium readable by the processor (including volatile and non-volatile memory and/or storage elements), at least one input device, and at least one output device. One or more programs may implement or utilize the processes described in connection with the presently disclosed subject matter, e.g., through the use of an application programming interface (API), reusable controls, or the like. Such programs may be implemented in a high level procedural or object-oriented programming language to communicate with a computer system. However, the program(s) can be implemented in assembly or machine language, if desired. In any case, the language may be a compiled or interpreted language and it may be combined with hardware implementations.


Implementations of the methods and systems may be described herein with reference to block diagrams and flowchart illustrations of methods, systems, apparatuses and computer program products. It will be understood that each block of the block diagrams and flowchart illustrations, and combinations of blocks in the block diagrams and flowchart illustrations, respectively, can be implemented by computer program instructions. These computer program instructions may be loaded onto a general purpose computer, special purpose computer, or other programmable data processing apparatus to produce a machine, such that the instructions which execute on the computer or other programmable data processing apparatus create a means for implementing the functions specified in the flowchart block or blocks.


These computer program instructions may also be stored in a computer-readable memory that can direct a computer or other programmable data processing apparatus to function in a particular manner, such that the instructions stored in the computer-readable memory produce an article of manufacture including computer-readable instructions for implementing the function specified in the flowchart block or blocks. The computer program instructions may also be loaded onto a computer or other programmable data processing apparatus to cause a series of operational steps to be performed on the computer or other programmable apparatus to produce a computer-implemented process such that the instructions that execute on the computer or other programmable apparatus provide steps for implementing the functions specified in the flowchart block or blocks.


Accordingly, blocks of the block diagrams and flowchart illustrations support combinations of means for performing the specified functions, combinations of steps for performing the specified functions and program instruction means for performing the specified functions. It will also be understood that each block of the block diagrams and flowchart illustrations, and combinations of blocks in the block diagrams and flowchart illustrations, can be implemented by special purpose hardware-based computer systems that perform the specified functions or steps, or combinations of special purpose hardware and computer instructions.


Example

Conventional aspiration systems operate with the vacuum being controlled with a “foot valve” by the operating physician. This is not very precise and is a distraction to the primary job of guiding the catheter. The principle of this system is to automate the process. The reader is directed to the flow chart of FIG. 9 for reference.


The system is controlled by a microprocessor controller (MC). A simple device as compared to a conventional computer and can run “stand alone”. That means all it needs to run is powering it up. The program is written to be failsafe and straightforward. On power up the MC initializes and performs a test of the system and a checksum on the program. Any problem with this stops the process. The system uses a Vacuum Regulator (VR) module. It takes raw unregulated vacuum from a user supplied vacuum pump (VP). The VR can be set to deliver from full to almost zero vacuum buy the MC while the VP is set to maximum vacuum.


Another component of the system is the Flow Sensor (FS). This device measures the amount of blood flow out of the catheter. There are several available technologies for the sensor. The most straight forward and inexpensive is the impeller rotational sensor. It measures the flow by how fast an impeller spins.


An ultrasonic flow sensor works well in this application and can accurately measure the low flow rates that might indicate the possibility of a blockage caused by a blood. A small tube from the catheter is placed in a cavity on the sensor and the velocity of the flow is determined. An electrical pulse train is produced that has a frequency proportional to the flow rate that is read by the MC. The sensor is completely isolated from any liquids and can be used repeatedly, where as the rotational sensor would have to be disposed of after every procedure.


In this example, 100 mL/minute is the upper limit on the flow rate. After power on test is complete, the VR commands full vacuum. The flow can reach 100 m/min quickly, and the MC detects that and quickly commands the VR to reduce vacuum and to control the flow by adjusting the vacuum to a midline flow rate of around 30 m/min. Without the VR, blood flow out of the catheter would be excessive.


The flow rate from 100 m/min to 30 mL/min can be achieved in steps so that the clinician gets enough time to make necessary decisions/actions. Same delay time or stepped approach is taken for the application of full vacuum to the aspiration tubing when the flow rate falls below a lower limit of 10 ml/min (or the tip of the catheter engages a clot, in practice).


If, while the system is regulating to 30 m/min, it drops below 10 m/min, a blockage of the catheter has probably occurred. The system will attempt to “Clear” the blockage, usually caused by encountering a blood clot, by commanding full vacuum power from the VR. As in the beginning, when the flow hits 100 m/min, the MC will command the VR will scale back and regulate to 30 mL/min.


The cycle repeats until the unit is shut off. Before complete shutdown, the MC commands the VR to completely release the vacuum.


The corresponding structures, materials, acts, and equivalents of all means or step plus function elements in the claims below are intended to include any structure, material, or act for performing the function in combination with other claimed elements as specifically claimed. The description of the present invention has been presented for purposes of illustration and description, but is not intended to be exhaustive or limited to the invention in the form disclosed. Many modifications and variations will be apparent to those of ordinary skill in the art without departing from the scope and spirit of the invention. The implementation was chosen and described in order to best explain the principles of the invention and the practical application, and to enable others of ordinary skill in the art to understand the invention for various implementations with various modifications as are suited to the particular use contemplated.

Claims
  • 1. A method of controlling blood loss during thrombus removal, the method comprising: fluidically connecting a vacuum pump to a vacuum line and fluidically connecting the vacuum line to a receptacle for blood collection;fluidically connecting the receptacle for blood collection to an aspiration tubing and fluidically connecting the aspiration tubing to an aspiration catheter;positioning the aspiration catheter within the vascular system of a subject;activating the vacuum pump;introducing a vacuum pressure and a flow of air into the vacuum line;introducing a vacuum pressure within the receptacle;initiating a flow of blood through the aspiration tubing via the vacuum pressure within the receptacle;collecting blood within the receptacle;measuring a flow parameter of the blood within the aspiration tubing using a sensor;receiving the flow parameter from the sensor at a vacuum controller;comparing the flow parameter to a target range for the flow parameter;sending an automatic control signal from the vacuum controller to a regulator based on a comparison of the flow parameter to the target range; andadjusting the vacuum pressure and flow of air within the vacuum line according to information stored in the automatic control signal, thereby adjusting the vacuum pressure within the receptacle and the flow of blood through the aspiration tubing and the aspiration catheter.
  • 2. The method of claim 1, wherein activating a vacuum pump comprises activating the vacuum pump at full power, and the vacuum controller adjusts the vacuum pressure within the vacuum line while the vacuum pump runs at full power.
  • 3. The method of claim 1, wherein adjusting the vacuum pressure within the vacuum line comprises manipulating a valve that opens the vacuum line to the atmosphere.
  • 4. The method of claim 1, wherein measuring a flow parameter comprises measuring a flow rate.
  • 5. The method of claim 1, further comprising using a plurality of sensors to measure one or more flow parameters of the blood at disparate points along the length of an aspiration lumen extending through the aspiration catheter and the aspiration tubing, and receiving the one or more flow parameters at the vacuum controller.
  • 6. The method of claim 1, further comprising measuring a frequency from the flow parameter at the vacuum controller.
  • 7. The method of claim 1, further comprising detecting air within the aspiration tubing and sending a leak signal to the regulator, the pump, or to the vacuum controller.
  • 8. The method of claim 7, wherein detecting air within the aspiration tubing or sending a leak signal to the regulator or the pump is delayed during a vacuum initialization period.
  • 9. The method of claim 1, further comprising accepting a manual command at a manual input, sending a first manual control signal responsive to the manual command to one or more of the vacuum controller, the regulator, or a receptacle vent, and stopping the vacuum controller from sending automatic control signals to the regulator.
  • 10. The method of claim 9, further comprising forming a second manual control signal at the vacuum controller based on the first manual control signal and sending the second manual control signal to the regulator and/or receptacle vent.
  • 11. The method of claim 9, further comprising receiving the first manual control signal at the regulator and controlling vacuum pressure within the vacuum line based on the manual control signal.
  • 12. The method of claim 9, further comprising receiving the first manual control signal at the receptacle vent and opening or shutting the receptacle vent based on the manual control signal.
  • 13. The method of claim 1, further comprising shifting a switch from a closed configuration to an open configuration, wherein shifting the switch to the open configuration causes a clamp coupled to the aspiration tubing to allow fluid flow through the aspiration tubing, and further comprising receiving a surge protection signal upon shifting of the switch to the open configuration and decreasing the vacuum pressure upon receipt of the surge protection signal.
  • 14. The method of claim 1, further comprising synchronizing the delivery of power between the vacuum pump and the vacuum controller.
  • 15. An aspiration system for controlling blood loss during thrombus removal, the aspiration system comprising: an aspiration catheter;an aspiration tubing fluidically coupled to the aspiration catheter;an aspiration lumen extending through the aspiration catheter and the aspiration tubing;a sensor configured to measure a blood flow parameter associated with blood within the aspiration lumen;a receptacle fluidically coupled to the aspiration tubing and configured to collect blood aspirated by the aspiration catheter;a vacuum line fluidically coupled to the receptacle and configured to transfer a vacuum pressure from a vacuum pump to the receptacle;a regulator coupled to the vacuum line, the regulator comprising a valve that is configured to open the vacuum line to the atmosphere in order to adjust the vacuum pressure within the vacuum line and within the receptacle; anda vacuum controller operably coupled to the sensor and the regulator and configured to communicate with the regulator to adjust the vacuum pressure within the vacuum line, the vacuum controller configured to: receive the blood flow parameter from the sensor;compare the blood flow parameter to a target range for the blood flow parameter; andsend an automatic control signal to the regulator based on a comparison of the blood flow parameter to the target range;wherein the automatic control signal causes the regulator to adjust the vacuum pressure within the vacuum line and within the receptacle by manipulating the valve that opens the vacuum line to the atmosphere.
  • 16. The aspiration system of claim 15, wherein the aspiration tubing is fluidically coupled to the receptacle at an intake port, and the vacuum line is fluidically coupled to the receptacle at a vacuum port.
  • 17. The aspiration system of claim 15, wherein the receptacle comprises a receptacle vent in communication with the regulator or the vacuum controller, the receptacle vent configured to open upon receipt of a venting signal from the regulator or vacuum controller.
  • 18. The aspiration system of claim 15, further comprising a plurality of sensors configured to measure one or more parameters associated with blood flow in the aspiration lumen at disparate points along a length of the aspiration lumen and to send measured parameters to the vacuum controller.
  • 19. The aspiration system of claim 15, further comprising an air leak sensor in communication with the vacuum controller or the regulator, the air leak sensor configured to detect air flow through the aspiration tubing and to send a leak signal to the vacuum controller, the regulator, or to a vacuum pump upon detection of air flow through the aspiration tubing.
  • 20. The aspiration system of claim 19, wherein the vacuum controller, the regulator, or the pump are configured to slow or stop a vacuum flow in the vacuum line while the air leak is addressed.
  • 21. The aspiration system of claim 20, wherein the vacuum controller is configured to delay detection of air leaks or to delay controlling the vacuum pressure in response to detection of air leaks during a vacuum initialization period.
  • 22. The aspiration system of claim 15, wherein the vacuum line comprises a disposable portion and a reusable portion, the disposable portion coupled to the reusable portion at a connector.
  • 23. The aspiration system of claim 15, further comprising a power synchronizer configured to detect power changes and cause the system to synchronize a delivery of power between a vacuum pump and the vacuum controller.
  • 24. The aspiration system of claim 15, further comprising a manual input in communication with one or more of the vacuum controller, the regulator, and a receptacle vent, wherein the manual input is configured to accept a manual command and send a manual control signal responsive to the manual command to one or more of the vacuum controller, the regulator, and the receptacle vent.
  • 25. The aspiration system of claim 15, further comprising an indicator in communication with the sensor, the indicator configured to inform a user of a characteristic of the blood flow parameter.
  • 26. The aspiration system of claim 15, wherein the aspiration system further comprises a clamp coupled to the aspiration tubing and a switch operably coupled to the clamp, the switch comprising a closed configuration and an open configuration, wherein the switch in the closed configuration causes the clamp to stop blood flow through the aspiration tubing, and wherein the switch in the open configuration causes the clamp to allow blood flow through the aspiration tubing.
  • 27. The aspiration system of claim 26, wherein the switch is in communication with the vacuum controller and/or the regulator, and shifting the switch to the open configuration sends a surge protection signal to the regulator and/or to the vacuum controller, and wherein upon receipt of the surge protection signal, the regulator and/or the vacuum controller is configured to reduce the vacuum pressure within the vacuum line.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 17/726,791, filed Apr. 22, 2022, which claims the benefit of U.S. Provisional Application 63/180,291, filed Apr. 27, 2021. Each of the aforementioned applications is incorporated herein by reference in its entirety for all purposes.

US Referenced Citations (734)
Number Name Date Kind
3693613 Kelman Sep 1972 A
3930505 Wallach Jan 1976 A
4244230 Bauer Jan 1981 A
4332560 Rait Jun 1982 A
4460361 Nichols Jul 1984 A
4654029 D'Antonio Mar 1987 A
4735606 Davidson Apr 1988 A
4935005 Haines Jun 1990 A
5094961 DelValle et al. Mar 1992 A
5195995 Walker Mar 1993 A
5201703 Gentelia Apr 1993 A
5242404 Conley et al. Sep 1993 A
5536242 Willard Jul 1996 A
5606968 Mang Mar 1997 A
5897524 Wortrich et al. Apr 1999 A
5941869 Patterson Aug 1999 A
6013046 Maaskamp et al. Jan 2000 A
6039715 Mackool Mar 2000 A
6055458 Cochran et al. Apr 2000 A
6258053 Mackool Jul 2001 B1
6290689 Delaney et al. Sep 2001 B1
6319223 Wortrich et al. Nov 2001 B1
6514268 Finlay et al. Feb 2003 B2
6629646 Ivri Oct 2003 B1
6663613 Evans et al. Dec 2003 B1
6730063 Delaney et al. May 2004 B2
6773445 Finlay et al. Aug 2004 B2
6790196 Kokate et al. Sep 2004 B2
6887220 Kataishi et al. May 2005 B2
6926208 Ivri Aug 2005 B2
6929633 Evans et al. Aug 2005 B2
6979293 Hansmann et al. Dec 2005 B2
7004931 Hogendijk Feb 2006 B2
7108197 Ivri Sep 2006 B2
7141045 Johansson et al. Nov 2006 B2
7160268 Darnell et al. Jan 2007 B2
7244250 Miki et al. Jul 2007 B2
7250042 Rauker et al. Jul 2007 B2
7276052 Kobayashi et al. Oct 2007 B2
7276060 Madden Oct 2007 B2
7309334 von Hoffmann Dec 2007 B2
7422579 Wahr Sep 2008 B2
7491192 Di Fiore Feb 2009 B2
7608063 Le et al. Oct 2009 B2
7655016 Demarais et al. Feb 2010 B2
7666161 Nash et al. Feb 2010 B2
7674272 Torrance et al. Mar 2010 B2
7713231 Wulfman et al. May 2010 B2
7713235 Torrance et al. May 2010 B2
7717934 Knsleika May 2010 B2
7736355 Itou et al. Jun 2010 B2
7762995 Eversull et al. Jul 2010 B2
7763010 Evans et al. Jul 2010 B2
7780694 Palmer et al. Aug 2010 B2
7792647 Ding et al. Sep 2010 B1
7842009 Torrance et al. Nov 2010 B2
7842010 Bonnette et al. Nov 2010 B2
7887510 Karpowicz Feb 2011 B2
7918822 Kumar et al. Apr 2011 B2
7931659 Bose et al. Apr 2011 B2
7935077 Thor et al. May 2011 B2
7938820 Webster et al. May 2011 B2
7942852 Mas et al. May 2011 B2
7947012 Spurchise et al. May 2011 B2
7959608 Nash et al. Jun 2011 B2
7976528 Nash et al. Jul 2011 B2
7981128 To et al. Jul 2011 B2
7998104 Chang Aug 2011 B2
8002728 Chang Aug 2011 B2
8007506 To et al. Aug 2011 B2
8012117 Bonnette et al. Sep 2011 B2
8021351 Boldenow et al. Sep 2011 B2
8052640 Fiorella et al. Nov 2011 B2
8057439 Di Fiore Nov 2011 B2
8066677 Lnnn et al. Nov 2011 B2
8066757 Ferrera et al. Nov 2011 B2
8070694 Galdonik et al. Dec 2011 B2
8070762 Escudero et al. Dec 2011 B2
8070791 Ferrera et al. Dec 2011 B2
8088103 Teeslink et al. Jan 2012 B2
8088140 Ferrera et al. Jan 2012 B2
8114106 Straub Feb 2012 B2
8137377 Palmer et al. Mar 2012 B2
8142442 Palmer et al. Mar 2012 B2
8157760 Criado et al. Apr 2012 B2
8162878 Bonnette et al. Apr 2012 B2
8231600 von Hoffmann Jul 2012 B2
8252020 Hauser et al. Aug 2012 B2
8262611 Teeslink et al. Sep 2012 B2
8298210 Provost-Tine et al. Oct 2012 B2
8303538 Bonnette et al. Nov 2012 B2
8317748 Fiorella et al. Nov 2012 B2
8323240 Wulfman et al. Dec 2012 B2
8337516 Escudero et al. Dec 2012 B2
8361105 Adams et al. Jan 2013 B2
8366663 Fiorella et al. Feb 2013 B2
8366735 Bose et al. Feb 2013 B2
8388582 Enbanks et al. Mar 2013 B2
8388628 Eversull et al. Mar 2013 B2
8398589 Teeslink et al. Mar 2013 B2
8405568 Knudsen et al. Mar 2013 B2
8430837 Jenson et al. Apr 2013 B2
8430840 Nazarifar et al. Apr 2013 B2
8435228 Wulfman et al. May 2013 B2
8439878 Bonnette et al. May 2013 B2
8444661 Nair et al. May 2013 B2
8460312 Bose et al. Jun 2013 B2
8465467 Gao Jun 2013 B2
8469970 Diamant et al. Jun 2013 B2
8475484 Wulfman et al. Jul 2013 B2
8500683 Constantz et al. Aug 2013 B2
8529491 Beiriger Sep 2013 B2
8535290 Evans et al. Sep 2013 B2
8545432 Renati et al. Oct 2013 B2
8545514 Ferrera Oct 2013 B2
8562555 MacMahon et al. Oct 2013 B2
8568432 Straub Oct 2013 B2
8574262 Ferrera et al. Nov 2013 B2
8585713 Ferrera et al. Nov 2013 B2
8591453 Stubkjaer et al. Nov 2013 B2
8628549 To et al. Jan 2014 B2
8647355 Escudero et al. Feb 2014 B2
8652086 Gerg et al. Feb 2014 B2
8657785 Torrance et al. Feb 2014 B2
8668665 Gerg et al. Mar 2014 B2
8679142 Slee et al. Mar 2014 B2
8679150 Janardhan et al. Mar 2014 B1
8690907 Janardhan et al. Apr 2014 B1
8696622 Fiorella et al. Apr 2014 B2
8702652 Fiorella et al. Apr 2014 B2
8715220 Gerg et al. May 2014 B2
8715314 Janardhan et al. May 2014 B1
8715315 Janardhan et al. May 2014 B1
8715316 Janardhan et al. May 2014 B1
8715317 Janardhan et al. May 2014 B1
8721676 Janardhan et al. May 2014 B1
8721677 Janardhan et al. May 2014 B1
8728116 Janardhan et al. May 2014 B1
8728117 Janardhan et al. May 2014 B1
8733618 Janardhan et al. May 2014 B1
8735777 Janardhan et al. May 2014 B1
8747432 Janardhan et al. Jun 2014 B1
8753371 Janardhan et al. Jun 2014 B1
8758325 Webster et al. Jun 2014 B2
8764724 Itou et al. Jul 2014 B2
8783151 Janardhan et al. Jul 2014 B1
8784355 Criado et al. Jul 2014 B2
8784434 Rosenbluth et al. Jul 2014 B2
8784446 Janardhan et al. Jul 2014 B1
8789452 Janardhan et al. Jul 2014 B1
8790365 Janardhan et al. Jul 2014 B1
8795330 Janardhan et al. Aug 2014 B1
8801749 Adams et al. Aug 2014 B2
8803030 Janardhan et al. Aug 2014 B1
8813625 Janardhan et al. Aug 2014 B1
8814892 Galdonik et al. Aug 2014 B2
8816247 Janardhan et al. Aug 2014 B1
8828045 Janardhan et al. Sep 2014 B1
8845678 Janardhan et al. Sep 2014 B1
8845679 Janardhan et al. Sep 2014 B1
8852219 Wulfman et al. Oct 2014 B2
8852227 Janardhan et al. Oct 2014 B1
8859934 Janardhan et al. Oct 2014 B1
8863631 Janardhan et al. Oct 2014 B1
8866049 Janardhan et al. Oct 2014 B1
8869670 Janardhan et al. Oct 2014 B1
8870805 Chang Oct 2014 B2
8870824 Kusakabe Oct 2014 B2
8870901 Janardhan et al. Oct 2014 B1
8870910 Janardhan et al. Oct 2014 B1
8872068 Janardhan et al. Oct 2014 B1
8882797 Janardhan et al. Nov 2014 B2
8888801 To et al. Nov 2014 B2
8895891 Janardhan et al. Nov 2014 B2
8900179 Jenson et al. Dec 2014 B2
8900257 Straub et al. Dec 2014 B2
8904914 Janardhan et al. Dec 2014 B2
8910555 Janardhan et al. Dec 2014 B2
8920402 Nash et al. Dec 2014 B2
8920448 To et al. Dec 2014 B2
8926680 Ferrera et al. Jan 2015 B2
8932320 Janardhan et al. Jan 2015 B1
8932321 Janardhan et al. Jan 2015 B1
8939931 von Hoffmann Jan 2015 B2
8940003 Slee et al. Jan 2015 B2
8945143 Ferrera et al. Feb 2015 B2
8945172 Ferrera et al. Feb 2015 B2
8951224 Wulfman et al. Feb 2015 B2
8956386 Hauser et al. Feb 2015 B2
8970384 Yodfat et al. Mar 2015 B2
8986241 Evans et al. Mar 2015 B2
8998843 Bonnette et al. Apr 2015 B2
9011364 Criado et al. Apr 2015 B2
9011467 Garrison et al. Apr 2015 B2
9017309 Tanikawa et al. Apr 2015 B2
9039715 Diamant et al. May 2015 B2
9050127 Bonnette et al. Jun 2015 B2
9055951 Deshpande Jun 2015 B2
9055963 Henkes et al. Jun 2015 B2
9072540 Jarnagin et al. Jul 2015 B2
9078682 Lenker et al. Jul 2015 B2
9095371 Escudero et al. Aug 2015 B2
9113936 Look et al. Aug 2015 B2
9119656 Leynov et al. Sep 2015 B2
9125728 Angel et al. Sep 2015 B2
9126018 Garrison Sep 2015 B1
9138527 Renati et al. Sep 2015 B2
9149568 Gerg et al. Oct 2015 B2
9161765 Thor et al. Oct 2015 B2
9161766 Slee et al. Oct 2015 B2
9179909 Garrison et al. Nov 2015 B2
9179931 Janardhan et al. Nov 2015 B2
9179995 Janardhan et al. Nov 2015 B2
9186487 Dubrul et al. Nov 2015 B2
9198679 To et al. Dec 2015 B2
9198687 Fulkerson et al. Dec 2015 B2
9220522 Fulkerson et al. Dec 2015 B2
9238122 Malhi et al. Jan 2016 B2
9239049 Jarnagin et al. Jan 2016 B2
9241699 Kume et al. Jan 2016 B1
9248221 Look et al. Feb 2016 B2
9259215 Chou et al. Feb 2016 B2
9259237 Quick et al. Feb 2016 B2
9265512 Garrison et al. Feb 2016 B2
9282989 Boukhny et al. Mar 2016 B2
9283040 Hendrick Mar 2016 B2
9295373 Torrance et al. Mar 2016 B2
9301829 Rauker et al. Apr 2016 B2
9308016 Escudero et al. Apr 2016 B2
9308315 Stubkjaer et al. Apr 2016 B2
9314263 Escudero et al. Apr 2016 B2
9314324 Janardhan et al. Apr 2016 B2
9320532 Ferrera et al. Apr 2016 B2
9332998 Ray et al. May 2016 B2
9332999 Ray et al. May 2016 B2
9333007 Escudero et al. May 2016 B2
9375223 Wallace Jun 2016 B2
9387098 Ferrera et al. Jul 2016 B2
9399118 Kume et al. Jul 2016 B2
9408620 Rosenbluth et al. Aug 2016 B2
9408626 Tekulve Aug 2016 B2
9408964 Breiter et al. Aug 2016 B2
9421080 Angel et al. Aug 2016 B2
9427300 Angel et al. Aug 2016 B2
9433427 Look et al. Sep 2016 B2
9445828 Turjman et al. Sep 2016 B2
9445943 Wilson et al. Sep 2016 B2
9463035 Greenhalgh et al. Oct 2016 B1
9492192 To et al. Nov 2016 B2
9492637 Garrison et al. Nov 2016 B2
9498604 Dubrul et al. Nov 2016 B2
9510854 Mallaby Dec 2016 B2
9522258 Tekulve Dec 2016 B2
9526504 Chang Dec 2016 B2
9526864 Quick Dec 2016 B2
9526865 Quick Dec 2016 B2
9526874 Teeslink et al. Dec 2016 B2
9526922 Hossack et al. Dec 2016 B2
9532792 Galdonik et al. Jan 2017 B2
9539022 Bowman Jan 2017 B2
9549850 Sorensen et al. Jan 2017 B2
9554822 Consigny Jan 2017 B2
9561345 Garrison et al. Feb 2017 B2
9592068 Janardhan et al. Mar 2017 B2
9597101 Galdonik et al. Mar 2017 B2
9629654 Andersen Apr 2017 B2
9649437 Eubanks et al. May 2017 B2
9655633 Leynov et al. May 2017 B2
9655755 Chou et al. May 2017 B2
9656043 Bhagchandani et al. May 2017 B2
9662118 Chang May 2017 B2
9662129 Galdonik et al. May 2017 B2
9662137 Jenson et al. May 2017 B2
9662480 Kume et al. May 2017 B2
9668767 To et al. Jun 2017 B2
9669191 Chou et al. Jun 2017 B2
9675376 To et al. Jun 2017 B2
9681882 Garrison et al. Jun 2017 B2
9693898 Farley et al. Jul 2017 B2
9700332 Marchand et al. Jul 2017 B2
9700347 Shiber Jul 2017 B2
9707002 Henkes et al. Jul 2017 B2
9717519 Rosenbluth et al. Aug 2017 B2
9731065 Bourne et al. Aug 2017 B2
9737328 Bonnette et al. Aug 2017 B2
9750517 Agrawal Sep 2017 B2
9750524 Janardhan et al. Sep 2017 B2
9775964 Eubanks et al. Oct 2017 B2
9789242 Criado et al. Oct 2017 B2
9801642 Thor et al. Oct 2017 B2
9801643 Hansen et al. Oct 2017 B2
9801644 Ulm, III Oct 2017 B2
9808266 Ray et al. Nov 2017 B2
9808271 Ulm, III Nov 2017 B2
9808277 Nash et al. Nov 2017 B2
9814478 Ulm, III Nov 2017 B2
9820761 Garrison et al. Nov 2017 B2
9820764 Ulm, III Nov 2017 B2
9826998 Ulm, III Nov 2017 B2
9833251 Janardhan et al. Dec 2017 B2
9833253 Ulm, III Dec 2017 B1
9833257 Bonnette et al. Dec 2017 B2
9833555 Criado et al. Dec 2017 B2
9839506 Ulm, III Dec 2017 B2
9839771 Eversull et al. Dec 2017 B2
9844387 Marchand et al. Dec 2017 B2
9848881 Sutton et al. Dec 2017 B2
9848975 Nash et al. Dec 2017 B2
9855375 Charron et al. Jan 2018 B2
9861783 Garrison et al. Jan 2018 B2
9878076 Gulcher et al. Jan 2018 B2
9883877 Look et al. Feb 2018 B2
9895158 Dixon et al. Feb 2018 B2
9895473 Look et al. Feb 2018 B2
9901435 Janardhan et al. Feb 2018 B2
9907567 Shiber Mar 2018 B2
9913936 Look et al. Mar 2018 B2
9925315 Eubanks et al. Mar 2018 B2
9931166 Sauro et al. Apr 2018 B2
9931447 Layser et al. Apr 2018 B2
9943321 Nita Apr 2018 B2
9943668 Jahrmarkt Apr 2018 B2
9955987 Ulm, III May 2018 B2
9962177 Ulm, III May 2018 B2
9962288 Yalamanehili May 2018 B2
9987028 Lowinger et al. Jun 2018 B2
10004531 Rosenbluth et al. Jun 2018 B2
10010657 Torrance et al. Jul 2018 B2
10016211 Ferrera et al. Jul 2018 B2
10016266 Hauser Jul 2018 B2
10022139 Kobayashi et al. Jul 2018 B2
10039906 Kume et al. Aug 2018 B2
10045790 Cox et al. Aug 2018 B2
10058339 Galdonik et al. Aug 2018 B2
10064643 Malhi et al. Sep 2018 B2
10085864 Chou et al. Oct 2018 B2
10098651 Marchand et al. Oct 2018 B2
10098724 Adams et al. Oct 2018 B2
10117669 Kobayashi et al. Nov 2018 B2
10117670 Kobayashi et al. Nov 2018 B2
10137034 Heeren Nov 2018 B2
10143489 Kobayashi et al. Dec 2018 B2
10149692 Turjman et al. Dec 2018 B2
10149698 Wulfman et al. Dec 2018 B2
10154853 To et al. Dec 2018 B2
10154854 To et al. Dec 2018 B2
10179224 Yang et al. Jan 2019 B2
10182940 Chandrakant et al. Jan 2019 B2
10183145 Yang et al. Jan 2019 B2
10183146 Yang et al. Jan 2019 B2
10183147 Yang et al. Jan 2019 B2
10188399 Chang Jan 2019 B2
10188409 Smalling Jan 2019 B2
10192230 Look et al. Jan 2019 B2
10201359 Fiorella et al. Feb 2019 B2
10213582 Garrison et al. Feb 2019 B2
10219814 Feltyberger et al. Mar 2019 B2
10226263 Look et al. Mar 2019 B2
10226268 Ulm, III Mar 2019 B2
10226275 Eseudero et al. Mar 2019 B2
10226563 Garrison et al. Mar 2019 B2
10226598 Chou et al. Mar 2019 B2
10238406 Cox et al. Mar 2019 B2
10238853 Kume et al. Mar 2019 B2
10251739 Janardhan et al. Apr 2019 B2
10258358 Ulm, III Apr 2019 B2
10271864 Greenhalgh et al. Apr 2019 B2
D847864 Janardhan et al. May 2019 S
D847865 Janardhan et al. May 2019 S
D847866 Janardhan et al. May 2019 S
10278719 Ulm, III May 2019 B2
10278861 Bourne et al. May 2019 B2
10285720 Gilvarry et al. May 2019 B2
10299824 Walzman May 2019 B2
D850490 Janardhan et al. Jun 2019 S
10307242 Walzman Jun 2019 B2
10314608 Jenson et al. Jun 2019 B2
10314609 Bonnette et al. Jun 2019 B2
10314684 Walzman Jun 2019 B2
10314953 Ovehinnikov et al. Jun 2019 B2
10321925 Ulm, III Jun 2019 B2
10327790 Garrison et al. Jun 2019 B2
10335186 Rosenbluth et al. Jul 2019 B2
10335260 Janardhan et al. Jul 2019 B2
10342571 Marchand et al. Jul 2019 B2
10342655 Janardhan et al. Jul 2019 B2
10349960 Quick Jul 2019 B2
10357242 Garrison et al. Jul 2019 B2
10357266 Ulm, III Jul 2019 B2
10363054 Vale et al. Jul 2019 B2
10369270 Stubkjaer et al. Aug 2019 B2
10369346 Ryan et al. Aug 2019 B2
10376678 Levine Aug 2019 B2
10376685 Angel et al. Aug 2019 B2
10383644 Molaei et al. Aug 2019 B2
10384034 Garrison et al. Aug 2019 B2
10390926 Janardhan et al. Aug 2019 B2
10398595 Zacharias Sep 2019 B2
10405924 Bowe Sep 2019 B2
10413310 Ferrera et al. Sep 2019 B2
10420572 Ulm, III Sep 2019 B2
10426511 Hehrlein Oct 2019 B2
10426885 Criado et al. Oct 2019 B2
10441301 Vale et al. Oct 2019 B2
10441745 Yang et al. Oct 2019 B2
10448969 Sutton et al. Oct 2019 B2
10456151 Slee et al. Oct 2019 B2
10456555 Garrison et al. Oct 2019 B2
10463351 Merk et al. Nov 2019 B2
10463386 Ogle et al. Nov 2019 B2
10463468 Janardhan et al. Nov 2019 B2
10470926 Zacharias Nov 2019 B2
10471233 Garrison et al. Nov 2019 B2
10485551 Turjman et al. Nov 2019 B2
10485564 Goyal Nov 2019 B2
10485565 Galdonik et al. Nov 2019 B2
10485952 Garrison et al. Nov 2019 B2
10492805 Culbert et al. Dec 2019 B2
10492809 Ulm, III Dec 2019 B2
10499944 Mallaby Dec 2019 B2
10517633 Nash et al. Dec 2019 B2
10524811 Marchand et al. Jan 2020 B2
10531882 Anand et al. Jan 2020 B2
10531883 DeVille et al. Jan 2020 B1
10537471 Look et al. Jan 2020 B2
10561440 Look et al. Feb 2020 B2
10569049 Garrison et al. Feb 2020 B2
10588655 Rosenbluth et al. Mar 2020 B2
10588656 Trosper et al. Mar 2020 B2
10595818 Levine Mar 2020 B2
10603415 Look et al. Mar 2020 B2
10610256 Bowman Apr 2020 B2
10617435 Vale et al. Apr 2020 B2
10617562 Bourne et al. Apr 2020 B2
10624659 Gamba et al. Apr 2020 B2
10632245 Enbanks et al. Apr 2020 B2
10646239 Garrison et al. May 2020 B2
10653434 Yang et al. May 2020 B1
10661053 Yang et al. May 2020 B2
10682152 Vale et al. Jun 2020 B2
10690127 Ochoa Jun 2020 B2
10695159 Hauser Jun 2020 B2
10702292 Look et al. Jul 2020 B2
10702415 Charles Jul 2020 B2
10702634 Luxon et al. Jul 2020 B2
10709466 Bowman et al. Jul 2020 B2
10709832 Criado et al. Jul 2020 B2
10716482 Anderson et al. Jul 2020 B2
10716583 Look et al. Jul 2020 B2
10716880 Culbert et al. Jul 2020 B2
10716915 Ogle et al. Jul 2020 B2
10722238 Sutton et al. Jul 2020 B2
10722239 Chang Jul 2020 B2
10722251 Garrison et al. Jul 2020 B2
10722253 DeVille et al. Jul 2020 B2
10722255 Leaker et al. Jul 2020 B2
10729455 Goyal et al. Aug 2020 B2
10743893 Garrison et al. Aug 2020 B2
10751159 Janardhan et al. Aug 2020 B2
10772644 Feltyberger et al. Sep 2020 B2
10772649 Hansen et al. Sep 2020 B2
10779835 Chang Sep 2020 B2
10779855 Garrison Sep 2020 B2
10786270 Yang et al. Sep 2020 B2
10792056 Vale et al. Oct 2020 B2
10799331 Hauser Oct 2020 B2
10828061 Bonnette et al. Nov 2020 B2
10835257 Ferrera et al. Nov 2020 B2
10835271 Ma Nov 2020 B2
10835272 Yang et al. Nov 2020 B2
10835278 Wilke et al. Nov 2020 B2
10835711 Yang et al. Nov 2020 B2
10864351 Garrison et al. Dec 2020 B2
10864357 Kume et al. Dec 2020 B2
10869956 Torrance et al. Dec 2020 B2
10874410 Scarpine et al. Dec 2020 B2
10874411 Ngnyen et al. Dec 2020 B2
10888346 Ulm, III Jan 2021 B2
10893881 Dixon et al. Jan 2021 B2
10893978 Sawicz Jan 2021 B2
10905448 Machi Feb 2021 B2
10912577 Marchand et al. Feb 2021 B2
10912871 Gulcher et al. Feb 2021 B2
10922704 Look et al. Feb 2021 B2
10932797 Thomas Mar 2021 B2
10932810 Malhi et al. Mar 2021 B2
10939931 Grandfield et al. Mar 2021 B2
10952757 Galdonik et al. Mar 2021 B2
10952882 Chou et al. Mar 2021 B2
10959750 Wallace Mar 2021 B2
10960178 Savastano et al. Mar 2021 B2
10993731 Leynov et al. May 2021 B2
11013523 Arad Hadar May 2021 B2
11026709 Greenhalgh et al. Jun 2021 B2
11027104 Kume et al. Jun 2021 B2
11051832 Look et al. Jul 2021 B2
11051978 Heeren et al. Jul 2021 B2
11058445 Cox et al. Jul 2021 B2
11058451 Marchand et al. Jul 2021 B2
11065018 Buck et al. Jul 2021 B2
11077288 Govari Aug 2021 B2
11083485 Kobayashi et al. Aug 2021 B2
11083559 Kobayashi et al. Aug 2021 B2
11090070 Fiorella et al. Aug 2021 B2
11090071 Girdhar et al. Aug 2021 B2
11090466 Nicholson Aug 2021 B1
11096703 Panian Aug 2021 B2
11096712 Teigen et al. Aug 2021 B2
11096715 Hatta et al. Aug 2021 B2
11103265 Wallace et al. Aug 2021 B2
11116528 Wallace Sep 2021 B2
11123090 Yang et al. Sep 2021 B2
11129629 Welch et al. Sep 2021 B2
11147571 Cox et al. Oct 2021 B2
11147949 Yang et al. Oct 2021 B2
11160570 Skujins et al. Nov 2021 B2
11160571 Nguyen et al. Nov 2021 B2
11160572 Ulm, III Nov 2021 B2
11185623 Ovehinnikov et al. Nov 2021 B2
11185664 Garrison et al. Nov 2021 B2
11191558 Nguyen et al. Dec 2021 B2
11197683 Teigen et al. Dec 2021 B1
11197977 Mullins et al. Dec 2021 B2
11207096 To et al. Dec 2021 B2
11207456 Charron et al. Dec 2021 B2
11224458 Savastano et al. Jan 2022 B2
11224721 Garrison et al. Jan 2022 B2
11229445 Ogle Jan 2022 B2
11229451 Guerra et al. Jan 2022 B2
11229770 Chou et al. Jan 2022 B2
11234723 Ogle Feb 2022 B2
11253277 Buck et al. Feb 2022 B2
11259820 Walzman Mar 2022 B2
11259821 Buck et al. Mar 2022 B2
11266434 MeRae et al. Mar 2022 B2
11272945 Shrivastava et al. Mar 2022 B2
20030187475 Tsugita et al. Oct 2003 A1
20050004594 Nool Jan 2005 A1
20050020973 MacMahon Jan 2005 A1
20050159716 Kobayashi Jul 2005 A1
20050228423 Khashayar et al. Oct 2005 A1
20050240146 Nash et al. Oct 2005 A1
20070075161 Ivri Apr 2007 A1
20070129679 Bonnette et al. Jun 2007 A1
20070135779 Lalomia et al. Jun 2007 A1
20070239182 Glines Oct 2007 A1
20080103433 Nazarifar et al. May 2008 A1
20080147023 Hopkins et al. Jun 2008 A1
20100185150 Zacharias Jul 2010 A1
20100191169 Chang Jul 2010 A1
20100191170 Chang Jul 2010 A1
20100204672 Lockhart Aug 2010 A1
20110166496 Criado et al. Jul 2011 A1
20120041360 Gerg et al. Feb 2012 A1
20120059340 Larsson Mar 2012 A1
20130150782 Sorensen Jun 2013 A1
20130267919 Caso et al. Oct 2013 A1
20140271273 Carpenter Sep 2014 A1
20140303658 Bonnette et al. Oct 2014 A1
20140323906 Peatfield et al. Oct 2014 A1
20150283309 Look et al. Oct 2015 A1
20150327875 Look et al. Nov 2015 A1
20160089227 Loh Mar 2016 A1
20160128869 Zacharias May 2016 A1
20160296690 Kume et al. Oct 2016 A1
20160367272 Garrison et al. Dec 2016 A1
20170043066 Laub Feb 2017 A1
20170100142 Look et al. Apr 2017 A1
20170181760 Look Jun 2017 A1
20170239447 Yang et al. Aug 2017 A1
20170368309 Garrison et al. Dec 2017 A1
20180028359 Gordon et al. Feb 2018 A1
20180049920 Charles Feb 2018 A1
20180207397 Look et al. Jul 2018 A1
20180256177 Cooper et al. Sep 2018 A1
20180353194 Shaffer et al. Dec 2018 A1
20190108540 Look et al. Apr 2019 A1
20190125512 Macdonald et al. May 2019 A1
20190133616 Sachar et al. May 2019 A1
20190133617 Look et al. May 2019 A1
20190142567 Janardhan et al. May 2019 A1
20190142568 Janardhan et al. May 2019 A1
20190167287 Vale et al. Jun 2019 A1
20190167406 Janardhan et al. Jun 2019 A1
20190209745 Hanson et al. Jul 2019 A1
20190216476 Bose et al. Jul 2019 A1
20190239910 Brady et al. Aug 2019 A1
20190262120 Walzman Aug 2019 A1
20190274704 Jenson et al. Sep 2019 A1
20190307947 Stubkjaer Oct 2019 A1
20190328410 Look et al. Oct 2019 A1
20190350604 Slee et al. Nov 2019 A1
20190351182 Chou et al. Nov 2019 A1
20190366042 Garrison et al. Dec 2019 A1
20190374128 Palushi et al. Dec 2019 A1
20190381223 Culbert et al. Dec 2019 A1
20190381303 Angel et al. Dec 2019 A1
20190388109 Cai Dec 2019 A1
20200015826 Chang Jan 2020 A1
20200015840 Mallaby Jan 2020 A1
20200016369 Garrison et al. Jan 2020 A1
20200022711 Look et al. Jan 2020 A1
20200022712 Deville et al. Jan 2020 A1
20200023160 Chou et al. Jan 2020 A1
20200023164 Tran et al. Jan 2020 A1
20200029998 Ogle et al. Jan 2020 A1
20200038576 Garrison et al. Feb 2020 A1
20200046368 Merritt et al. Feb 2020 A1
20200046389 Galdonik et al. Feb 2020 A1
20200046939 Garrison et al. Feb 2020 A1
20200046940 Garrison et al. Feb 2020 A1
20200078029 Hansen et al. Mar 2020 A1
20200086083 Porter et al. Mar 2020 A1
20200093503 Deville et al. Mar 2020 A1
20200121336 Tsukamoto et al. Apr 2020 A1
20200121356 Look et al. Apr 2020 A1
20200155178 Culbert et al. May 2020 A1
20200164178 Garrison et al. May 2020 A1
20200170666 Trosper et al. Jun 2020 A1
20200179576 Wood Jun 2020 A1
20200179578 Look et al. Jun 2020 A1
20200187965 Garrison et al. Jun 2020 A1
20200187979 Bowman Jun 2020 A1
20200205840 Adawi et al. Jul 2020 A1
20200206457 Boling Jul 2020 A1
20200206458 Mullins et al. Jul 2020 A1
20200214726 Anand et al. Jul 2020 A1
20200215306 Garrison et al. Jul 2020 A1
20200246014 Walzman Aug 2020 A1
20200253624 Gamba et al. Aug 2020 A1
20200276411 Ogle et al. Sep 2020 A1
20200281610 Look et al. Sep 2020 A1
20200281611 Kelly et al. Sep 2020 A1
20200289136 Chou Sep 2020 A1
20200289722 Culbert et al. Sep 2020 A1
20200297362 DeVille et al. Sep 2020 A1
20200297363 Look et al. Sep 2020 A1
20200297365 Bowman et al. Sep 2020 A1
20200297410 Nguyen et al. Sep 2020 A1
20200297912 Criado et al. Sep 2020 A1
20200315642 Greenhalgh et al. Oct 2020 A1
20200316348 Ascher et al. Oct 2020 A1
20200324079 Jalgaonkar et al. Oct 2020 A1
20200337716 Garrison et al. Oct 2020 A1
20200345904 Casey et al. Nov 2020 A1
20200345981 Garrison et al. Nov 2020 A1
20200352583 Goyal et al. Nov 2020 A1
20200367917 Teigen et al. Nov 2020 A1
20200375616 Fitz et al. Dec 2020 A1
20200376175 Hartwell Dec 2020 A1
20200383698 Miao et al. Dec 2020 A1
20200397446 Chang Dec 2020 A1
20200397451 Feltyberger et al. Dec 2020 A1
20200397452 Twomey et al. Dec 2020 A1
20200397465 Nakano et al. Dec 2020 A1
20200397957 Teigen et al. Dec 2020 A1
20210022843 Hauser Jan 2021 A1
20210038236 Ma Feb 2021 A1
20210038779 Lorenzo Feb 2021 A1
20210045758 Garrison et al. Feb 2021 A1
20210045760 Ulm, III Feb 2021 A1
20210052296 Garrison Feb 2021 A1
20210068861 Bonnette et al. Mar 2021 A1
20210069467 Garrison et al. Mar 2021 A1
20210069468 Keating et al. Mar 2021 A1
20210077116 Ferrera et al. Mar 2021 A1
20210077134 Vale et al. Mar 2021 A1
20210085348 Nguyen Mar 2021 A1
20210085931 Green et al. Mar 2021 A1
20210093344 Janardhan et al. Apr 2021 A1
20210100974 Walzman Apr 2021 A1
20210100987 Sehultz et al. Apr 2021 A1
20210110419 Look et al. Apr 2021 A1
20210113224 Dinh Apr 2021 A1
20210121281 Walzman Apr 2021 A1
20210128182 Teigen et al. May 2021 A1
20210128893 Twomey et al. May 2021 A1
20210138193 Garrison et al. May 2021 A1
20210138194 Garrison et al. May 2021 A1
20210153883 Casey et al. May 2021 A1
20210161544 Casey Jun 2021 A1
20210161639 Walzman Jun 2021 A1
20210169509 Goyal Jun 2021 A1
20210170148 Green et al. Jun 2021 A1
20210186534 Hunt et al. Jun 2021 A1
20210219998 Thomas Jul 2021 A1
20210220109 Walzman Jul 2021 A1
20210220528 Jalgaonkar et al. Jul 2021 A1
20210228222 Porter Jul 2021 A1
20210228844 Ogle Jul 2021 A1
20210228847 Kume et al. Jul 2021 A1
20210236148 Marchand et al. Aug 2021 A1
20210236150 Arad Hadar Aug 2021 A1
20210236257 Walzman Aug 2021 A1
20210259719 Griffin Aug 2021 A1
20210267745 Walzman Sep 2021 A1
20210275197 Vale et al. Sep 2021 A1
20210298773 Echarri et al. Sep 2021 A1
20210298775 Nguyen et al. Sep 2021 A1
20210299343 Criado et al. Sep 2021 A1
20210322051 Hatta et al. Oct 2021 A1
20210322053 Kobayashi et al. Oct 2021 A1
20210322738 Kume et al. Oct 2021 A1
20210330332 Chou et al. Oct 2021 A1
20210338255 Alesi et al. Nov 2021 A1
20210346040 Panian Nov 2021 A1
20210353314 Porter Nov 2021 A1
20210353316 Wallace et al. Nov 2021 A1
20210353323 Teigen et al. Nov 2021 A1
20210361305 Mogi et al. Nov 2021 A1
20210378691 Panian Dec 2021 A1
20210378696 Yang et al. Dec 2021 A1
20210393280 Cortinas Villazon et al. Dec 2021 A1
20220000500 Arad Hadar et al. Jan 2022 A1
20220000502 Ulm, III et al. Jan 2022 A1
20220000505 Hauser Jan 2022 A1
20220000506 Hauser Jan 2022 A1
20220000507 Hauser Jan 2022 A1
20220008090 Look et al. Jan 2022 A1
20220015798 Marchand et al. Jan 2022 A1
20220022898 Cox et al. Jan 2022 A1
20220022899 Girdhar et al. Jan 2022 A1
20220022900 Nguyen et al. Jan 2022 A1
20220031931 Stout Feb 2022 A1
20220054150 Dholakia et al. Feb 2022 A1
20220054151 Shiffette Feb 2022 A1
20220054153 Albers et al. Feb 2022 A1
20220061870 Mintz Mar 2022 A1
20220061871 Mintz Mar 2022 A1
20220061872 Mintz Mar 2022 A1
20220062588 Mintz Mar 2022 A1
20220087696 Maini et al. Mar 2022 A1
20220168000 Naglreiter et al. Jun 2022 A1
20220338887 Nair et al. Oct 2022 A1
Foreign Referenced Citations (28)
Number Date Country
215386236 Jan 2022 CN
1996001079 Jan 1996 WO
2009012473 Jan 2009 WO
2008157674 Dec 2009 WO
2010075445 Jul 2010 WO
2013064852 May 2013 WO
20140151209 Sep 2014 WO
2017062927 Apr 2017 WO
2018019829 Feb 2018 WO
2019213179 Nov 2019 WO
2020023541 Jan 2020 WO
20200145928 Jul 2020 WO
20200167276 Aug 2020 WO
2021012058 Jan 2021 WO
2021016213 Jan 2021 WO
2021073572 Apr 2021 WO
2021083832 May 2021 WO
2021113962 Jun 2021 WO
2021113970 Jun 2021 WO
2021123395 Jun 2021 WO
2021151969 Aug 2021 WO
2021178696 Sep 2021 WO
2021242963 Dec 2021 WO
20210250133 Dec 2021 WO
2022020366 Jan 2022 WO
2022040615 Feb 2022 WO
2022174175 Aug 2022 WO
2023092042 May 2023 WO
Non-Patent Literature Citations (11)
Entry
US 11,191,563 B2, 12/2021, Savastano et al. (withdrawn)
International Search Report and Written Opinion issued for Application No. PCT/US2022/025918, dated Jun. 29, 2022.
Office Action issued for U.S. Appl. No. 17/726,787, dated Sep. 20, 2022.
Office Action issued for U.S. Appl. No. 17/726,787, dated Dec. 1, 2022.
Notice of Allowance issued for U.S. Appl. No. 17/726,787, dated Apr. 27, 2023.
Office Action issued for U.S. Appl. No. 17/726,788, dated Aug. 9, 2022.
Office Action issued for U.S. Appl. No. 17/726,788, dated Dec. 1, 2022.
Notice of Allowance issued for U.S. Appl. No. 17/726,788, dated May 5, 2023.
Office Action issued for U.S. Appl. No. 17/726,791, dated Jul. 26, 2022.
Office Action issued for U.S. Appl. No. 17/726,791, dated Nov. 30, 2022.
Notice of Allowance issued for U.S. Appl. No. 17/726,791, dated Apr. 23, 2023.
Related Publications (1)
Number Date Country
20230256155 A1 Aug 2023 US
Provisional Applications (1)
Number Date Country
63180291 Apr 2021 US
Continuations (1)
Number Date Country
Parent 17726791 Apr 2022 US
Child 18140280 US